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ABSTRACT 
 
Background: Mental retardation (MR) is still a major health problem worldwide. 
Genetic factors play a significant role in MR. In Indonesia, only a few genetic 
studies have been performed in the MR population so far. 
 
Objective: To identify major genetic causes of mental retardation, excluding 
Down Syndrome, in Semarang Jawa-Tengah Indonesia, including cytogenetics, 
Fragile-X Syndrome, Sub-telomeric deletions and duplications (STDs), Prader-
Willi Syndrome (PWS) and Angelman Syndrome (AS). In addition, to establish a 
MR diagnosis protocol for future studies that will be conducted in the Indonesian 
population. 
 
Methods: A total of 122 mentally retarded pupils from three special schools were 
screened for cytogenetic abnormalities and CGG repeats in the FMR-1 gene. 
Subsequently, they were screened for STDs and for PWS/AS using Multiplex 
Ligation-dependent Probe Amplification (MLPA) analysis. All pupils were 
clinically examined following an adapted diagnostic protocol from the RUNMC. 
The members of one family of an affected male pupil with a full CGG repeat 
expansion of the FMR-1 gene were also screened for CGG repeats and Southern 
Blot analysis were performed. 
 
Results: A full CGG repeat expansion was identified in one subject and a mosaic 
pattern of expansions in the premutation range and full mutation was identified in 
another subject respectively. In the 1 Fragile-X family showed two premutation 
female carriers, two males with mosaic pattern in the premutation range and one 
female with a full mutation. Sub-telomeric deletions and/or duplications were 
identified in 13 samples. Sub-telomeric deletions and duplications results are 
discussed. None of the selected samples for PWS/AS analysis were positive.  
 
Conclusions: This study showed that several genetic factors contribute to and 
play a role in the development of MR in Indonesia. A standardized MR clinical 
examination protocol, adapted from the RUNMC, can be used for further research 
in Indonesia. 
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ABSTRAK 
 
Latar Belakang:   
Retardasi mental masih merupakan masalah kesehatan dunia termasuk di Negara-
negara maju. Faktor genetik berperan secara signifikan sebagai penyebab retardasi 
mental. Sampai saat ini, baru sedikit penelitian genetik pada populasi retardasi 
mental di Indonesia. 
 
Metode: 
Skrining abnormalitas sitogenetik dan pengulangan CGG pada gen FMR-1 telah 
dilakukan pada 122 murid SLB. Selanjutnya pada populasi tersebut dilakukan 
skrining untuk mikro duplikasi dan mikro delesi sub telomerik dan untuk sindrom 
Prader-Willi/Angelman menggunakan teknik MLPA. Pemeriksaan fisik 
menggunakan protokol diagnostik yang diadaptasi dari RUNMC telah dilakukan 
pada semua siswa. Anggota keluarga penderita Fragile-X juga telah diskrining 
untuk pengulangan CGG dan analisis Southern Blotting. 
 
Hasil: 
Satu siswa teridentifikasi dengan Full mutasi dan satu siswa lainnya teridentifikasi 
memiliki mosaik antara full mutasi dengan premutasi. Pada keluarga dengan 
Fragile-X, dua wanita merupakan karier premutasi, dua pria mempunyai pola 
mosaik dalam batas premutasi. Delesi dan duplikasi subtelomerik telah 
teridentifikasi pada 13 siswa. Hasil delesi dan duplikasi sub-telomerik ini 
didiskusikan. Dari sampel yang dipilih untuk pemeriksaan PWS/AS tidak satupun 
ditemukan hasil positif. 
 
Kesimpulan: 
Pada penelitian ini ditunjukkan bahwa beberapa faktor genetik berkontribusi dan 
mempunyai peran sebagai penyebab RM di Indonesia. Protokol pemeriksaan 
klinis yang diadaptasi dari RUNMC bisa digunakan untuk penelitian selanjutnya 
di Indonesia. 
CHAPTER I 
INTRODUCTION 
 
I.1. Background 
Mental retardation (MR) is still a major health problem in all countries 
including the developed countries. Besides the fact that educational and psychological 
aspects regarding MR need more attention, some cases of severe MR require nursery, 
guidance, and surveillance as long as they live1.Some etiologies of MR are known, 
like biochemical causes, chromosomal abnormalities, mutations of single gene 
(Mendelian disorders/mitochondrial disorders), multi-factorial disorders or because of 
environmental factors such as toxins, infections, and trauma. However, genetic factors 
have a crucial role since approximately half of MR cases have a familial history2. 
About 38.545 Pupils have been registered in special schools for mentally 
retarded for the whole of Indonesia3, but this does not represent the total number of 
MR pupils in Indonesia. Factors such as lack of awareness, parents’ educational 
background, availability of special schools (in some areas), and economic background 
could be the few reasons why children with MR are not formally schooled. Semarang 
is the capital of Central Java province with total residents of 1.389.4164. Most 
residents in this city include Javanese, Chinese and other ethnic groups in a small 
percentage. Semarang has 8 special schools for MR children with a total number of 
942 pupils3. Indonesia is a developing country, where health insurance is not at all 
mandatory for all the citizens making mentally retarded children really a big problem 
for the family both financially and morally. Therefore, early diagnosis and prevention 
of MR should be one of the top health priorities.  
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The knowledge of genetic factors of mental retardation by cytogenetics, 
molecular and clinical assessment is an advantage in giving early diagnosis and 
prevention through genetic counseling to subject’s family. These serve as diagnostics 
tool in determining genetic factor that may play role as etiological cause of MR. 
Nowadays, the above mentioned assessments could well be done in Indonesia. But 
due to lack of facilities in Indonesia, further molecular assessments have to be carried 
out in other centre abroad.  
 Up till now there are only few studies on MR in Indonesian population carried 
out by Indonesian researchers or in collaboration with researchers abroad. No MR 
protocol has been applied for diagnosis of MR in Indonesia, thus this study aims to 
establish MR protocol for diagnosis in Indonesia. More over genetic assessments as 
an etiological diagnostic tool for MR have not yet been recognized as a routine 
diagnostic tool in Indonesia. The procedures for genetics assessment will be the main 
focus of this research in order to apply this MR protocol for diagnosis in Indonesia. 
 
I.2. Research Questions  
1.2.1 General Research Question 
 What is the percentage of genetic factors playing a role in the etiology of 
mental retardation in Indonesian Population? 
 
1.2.2 Research question in detail 
1. What are the genetic factors that causing MR in Semarang? 
2. Is there any clinical phenotype genotype association resulted by cytogenetics 
and molecular analysis? 
 
 3
1.3. Research purposes 
 1.3.1 General research purposes 
The purposes of this research include: 
1. To identify major genetic causes of mental retardation in Semarang, Jawa-
Tengah Indonesia.  
2. Establishing MR diagnosis protocol for Indonesian subjects is one of the 
major importances of this research.  
 
1.3.2. Specific research purposes 
1. To determine if  genetic factors are responsible for  mental retardation in 
Semarang 
2. To find out the frequency of chromosomal abnormalities excluding Down 
Syndrome in special schools in Semarang. 
3. To asses and evaluate the implementation of diagnostic protocols been 
employed in the developed countries. 
 
1.4. Research advantages: 
1. To encourage public awareness of genetic diseases. Infectious diseases are still 
top concern for government and medical organizations. Therefore starting a 
large population based genetic survey in Indonesia will possibly increase this 
public awareness. For stakeholders it is a very important concern to provide 
awareness about the role of genetics for such a major health problem like 
mental retardation. 
2. To lay down a basis for genetic counseling. Genetic counseling is not that 
common in Indonesia, though with increasing public awareness in genetic 
 4
diseases there will be an increasing demand for genetic counseling. Genetic 
counselors should be able to recognize genetic heterogeneity with geographic 
and ethnic differences. The results of this research should become a basis for 
genetic counselors when giving counseling to the parents. 
 
1.5. Research Originality 
1. Screening on Fragile-X and cytogenetic in individual with 
Mental Retardation in Indonesia have been performed initially 
by Faradz et al 5-7. 
2. Screening on PW/AS and STDs in individual with Mental 
Retardation in Indonesia is the first study in Indonesia. 
CHAPTER II 
LITERATURE REVIEW 
 
II.1 Mental Retardation 
II.1.1 Definiton and Etiology 
Mental retardation (MR) refers to substantial limitations in present 
functioning. It is characterized by significant subaverage intellectual functioning i.e 
IQ < 70, existing concurrently with related limitations in two or more of the following 
applicable adaptive skill areas: communication, self-care, home living, social skills, 
community use, self-direction, health and safety, functional academics, leisure and 
work. The  age of onset should be before age 188.  
Many environmental and genetic factors can cause MR like biochemical 
causes, chromosomal abnormalities, mutations of single gene (Mendelian 
disorders/mitochondrial disorders), multi-factorial disorders or because of 
environmental factors such as toxins, infections, and trauma9. Nevertheless, genetic 
factors have a crucial role since approximately half of MR cases have a familial 
history2. 
II.1.2. Genetic Causes 
Several genetic causes of MR are known, most common are the large 
microscopic numerical and structural cytogenetic abnormalities (> 4 MB), such as 
trisomy 21 (Down syndrome), large deletions and duplications and unbalanced 
reciprocal and Robertsonian translocations10. Down syndrome is the best known 
chromosomal abnormality as cause of MR with the highest prevalence. This 
abnormality occurs due to meiotic non-disjunction, mostly maternal with a result an 
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extra 21 chromosome in the child. With routine chromosomal analysis, trisomies like 
trisomy 21 can be easily detected10. 
Individuals with MR, dysmorphic features with or without positive family 
history (usually without positive family history) and without microscopic 
chromosomal abnormalities can be due to cryptic chromosomal rearrangements like 
sub-microscopic sub-telomeric deletions or duplications. This has been identified as 
another common cause of MR11,12. 
Chromosome ends (telomeres) consist of TG-rich hexamere (TTAGGG)n and 
repeated several thousand times. Next to the telomeres there is the sub-telomeric 
region located; consisting of complex families of repetitive DNA sequences13. These 
telomeric regions are the highest gene concentrations in the human genome and 
extremely gene rich14. Abnormalities in this region are associated with severe 
phenotypic consequences and estimated to account for approximately 5% of mental 
retardation11. Some studies by Knight et al, Koolen et al, Rooms et al and Nothrop et 
al. has led to awareness that subtelomeric deletions below the level of light 
microscopes are significant cause of mental retardation12,15-17. 
Penrose in 1938 was first to observe that more males than females in the 
population are mentally retarded in a survey and classification of those in institutional 
care and their relatives. In 1970’s Lehrke was first to suggest that there may be genes 
coding for intellectual function located in X chromosome18. This hypothesis has been 
substantiated by numerous subsequent studies in many countries and an 
approximately 30% excess of males being affected with mental retardation19-21 . As 
illustrated in Table 1, excess of male pupils are also shown in Semarang with male-to-
female ratio was 1,31. The excess male pupils than female pupil in our population 
were observed to be similar with previous studies above.  
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Table 1.Gender distribution of pupils in Semarang special school term 2005/2006 
No. School Name Male Pupils Female  Pupils Total Pupils 
1. SLB YPAC Semarang 95 77 162 
2. SLB Swadaya  26 27 53 
3. SLB Widya Bhakti  121 95 216 
4. SLB Pelita Ilmu  24 12 36 
5. SLB Hj. Sumiyati  30 18 48 
6. SLB Dharma Mulia  29 26 55 
7. SLB Immanuel  14 4 18 
8 SLB Negri Semarang  26 19 45 
 Total 365 278 643 
Data were taken from each school at preliminary study. 
 
X-Linked Mental Retardation (XLMR) can be generally classified into two 
categories; syndromic XLMR (S-XLMR) that are associated with a specific or 
characteristic phenotype and non-syndromic XLMR (NS-XLMR) that do not present 
with consistent clinical features22. Non-syndromic XLMR was thought to be more 
frequent than the syndromic XLMR conditions21,23. Nevertheless, due to the 
development of molecular techniques which is used to classify family and better 
detailed examination in the patient, the proportion of S-XLMR will be increase 
simultaneously with the decrease of NS-XLMR 22. 
Fragile-X syndrome is one of the XLMR and become the most common 
inherited abnormality causing MR24. This syndrome is commonly seen in males. 
However, females can also be affected. Approximately 50-60% of female full 
mutation carriers will have borderline to mild mental retardation25. The Fragile X 
syndrome is due to a mutation in a gene on the X chromosome leading to hyper-
expansion of a trinucleotide (CGG) repeat sequence. There is a repetitive CGG 
sequence on the 5’ÚTR of the FMR1 gene and normal individuals have approximately 
5 to 44 CGG repeats. There is a gray zone of 45 to 54 repeats that can be associated 
with minor instability from generation to generation. The premutation is defined as 55 
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to 200 repeats and the full mutation of the FMR1 gene involves an expansion of >200 
CGG repeats and is clinically associated with features of Fragile-X syndrome26-27.  
The diagnostics for Fragile-X syndrome is principally based on Southern 
blotting (DNA digested with specific restriction endonucleases) or on direct 
amplification of the CGG-repeat using flanking primers. Using standard PCR 
amplification, alleles that have repeats above 120 CGGs are difficult to detect, but 
PCR amplification is needed to obtain accurate sizing of permutations26,28. This is 
crucial to calculate the risk of having affected children for carrier females, and to 
distinguish intermediate/gray zone alleles from permutations25,28 
Panagopoulos et al. and Pena et al reported a possibility to diagnose FXS 
using Methylation Specific PCR (MS-PCR) of the FMR-1 locus. This technique is 
promising a possibility to amplify bigger size of fragment which was not possible to 
amplify with regular PCR before29,30. Nevertheless, this technique had a limitation. 
Although the method can be used to analyze female individuals, there is an additional 
problem due to the methylation of the inactive X chromosome30. 
There are other methods to detect FXS. Willemsen et al invented a non-
invasive technique to detect FXS based on FMRP specific antibody in the hair root31.  
Recently, Tassone et al invented a rapid polymerase chain reaction (PCR)-based 
screening tool for expanded FMR1 alleles. This method uses a chimeric PCR primer 
that targets randomly within the expanded CGG region32.  
Prader-Willi and Angelman syndrome are genetic disorders that show 
different levels of mental retardation. Prader-Willi syndrome (PWS) features mild to 
moderate mental retardation and Angelman syndrome (AS) severe mental 
retardation32,33. These syndromes can occur due to absence of the paternally or 
maternally derived chromosome 15q11-13 region by several genetic mechanisms. 
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When there is absence of paternal chromosome 15q11-13 region it will manifest as 
Prader-Willi Syndrome, while absence of the maternal chromosome 15q11-13 region 
will manifest as Angelman syndrome34-36.  
High-resolution chromosome studies at the 650-band level and in particular 
fluorescence in situ hybridization (FISH) testing could detect individuals with PWS 
and AS, because approximately 70% individuals with PWS and AS have a deletion of 
one chromosome 15 involving bands 15q11-q13. Whereas in PWS uniparental 
maternal disomy occurs in about 25% of cases, in AS  uniparental paternal disomy 
occurs in only 1% of cases. Both syndromes and in particular AS can also be caused 
by mutations in imprinted genes with potentially high recurrence risks37. 
II.1.3 Genetic diagnosis 
Genetics diagnosis for MR individual is based on dysmorpologycal and 
laboratory assesement. Most known genetics syndrome in MR is associated with 
specific features10. Laboratory assessment is considered as the tool to confirm the 
genetics diagnosis based on clinical examination. Nevertheless, some genetics 
etiology could not be diagnosed with dysmorphologycal assessment10. Thus, 
laboratory assesement is needed10,12. However, dysmorphologycal assessment is the 
most important thing to do before laboratory and other assessment.   
Chromosomal analysis is the most valuable analysis to reveal genetics cause 
of MR. With routine chromosomal analysis, numerical abnormalities such as trisomy 
13,18, and 21 or monosomy such as monosomy X (45,X/Turner syndrome) can be 
easily detected10. Furthermore chromosomal analisys can reveal some structural 
chromosome abnormality such as deletion / duplication (> 4 Mb), insertion, 
derivation, and translocation.  That is why; we do the chromosome analysis as the first 
laboratory assessment for the patient.  
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Since Fragile-X syndrome is considered as the most common inherited 
abnormality causing MR24. Laboratory analysis for the Fragile-X syndrome is the 
most significant assessment after chromosome analysis. Although fragile site in the 
Fragile-X syndrome is detected in chromosomal analysis, nevertheless subject with 
permutation or mosaic permutation – full mutation of Fragile-X syndrome might not 
detected by routine chromosome analysis. That is why; we have to do confirmation 
analysis with molecular assessment. 
Subtelomeric deletions and duplications (< 4Mb) are not visible by 
microscope12. Thus molecular analysis of this abnormality is required. Based on the 
high incidence of this abnormality in MR individual11,12,15-17, molecular screening of 
this abnormality is very important if the chromosome analysis and Fragile-X analisys 
are fail to detect the genetic cause of MR. 
PW/AS analysis could be performed to the MR individual with suspicion of 
this abnormality. Since there are some genetics diseases have similar features with 
PW/AS syndrome, this analysis is valuable to verify genetic diagnosis of MR 
especially to the MR individuals with suspicion of this syndrome37. 
 
 
 11
II.2. Theoretical Scheme 
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II.3. Conceptual Frame 
II.3.1. First screening steps  
 
 
 
 
 
 
 
 
 
 
 
 
II.3.2. MR Pupil with positive laboratory results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Selected pupils from 
special school 
Cytogenetics 
Analysis 
Chromosomal 
aberrations
Normal 
Karyotype 
DNA analysis: 
FMR-1 
MLPA 
PW/AS 
Specific mutation
No mutation
Confirmation with different 
analysis if applicable and 
parent blood sample analysis 
Pupil with positive 
laboratory result 
Home visit Blood sampling for each 
affected family members, 
healthy siblings and parents 
Cytogenetic 
Analysis 
Chromosomal 
aberrations
Normal 
Karyotype 
Specific mutation 
No mutation 
DNA analysis 
 13
 
II.3.3 Molecular analysis scheme 
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CHAPTER III 
RESEARCH METHODOLOGY 
 
III.1. Research aspects 
III.1.1 Research field 
This research project is in the field of human genetics particularly 
cytogenetics and molecular genetics inter-correlated with pediatrics 
and clinical genetics. 
III.1.2 Research location 
Pupils have been examined from several special schools for the 
mentally retarded in Semarang namely SLB Negeri, SLB Pelita Ilmu, 
and SLB Hj. Soemijati. Routine chromosome analysis was performed 
in Molecular and Cytogenetic laboratory of Center for Biomedical 
Research, Faculty of Medicine Diponegoro University Semarang. 
DNA analysis of the Fragile-X syndrome, Prader-Willi/Angelman 
syndrome and sub-telomeric deletions and deletions (STDs Analysis) 
with MLPA (Multiplex Ligation Probe Amplification were performed 
in the Radboud University Nijmegen (Laboratory for DNA 
diagnostics, RUNMC). 
III.1.3. Research period  
This research conducted within 1.5 year with sample collection in the 
1st semester continued with Cytogenetic preparation and DNA 
extraction. In 2nd and 3rd semester for molecular analysis was carried 
out in Nijmegen. 
 15
   
III.1.4 Research design 
 This study is a observational survey. 
 
III.2 Material 
III.2.1 Population 
Mentally retarded pupils of several special schools in Semarang (SLB 
Hj. Soemijati, SLB Pelita Ilmu, and SLB Negeri ) were  included in 
this study. 
III.2.2. Samples 
Samples were taken from 122 mentally retarded pupils with an average 
age between 6 and 25 years (Table 4). The parents were also involved 
in order to obtain the family history. Furthermore, samples of parents, 
of pupils with a proven genetic abnormality, were taken in order to 
determine de novo or inherited occurrence. Not all parents were 
available for sampling. 
 
Table 4.  Total amount samples obtained from special schools in 
Semarang 
School Name Males Females  Total 
Hj. Soemijati 23 14 37 
Pelita Ilmu 19 5 24 
Negeri 52 9 61 
Total 94 28 122 
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III.2.2.1 Inclusion criteria 
Mentally retarded pupils (clinically diagnosed MR with AAMR 
criteria) from three special schools, whose parents signed the informed 
consent form, were included in this research project.  
 
III.2.2.2 Exclusion criteria 
Pupils with a known exogenic cause, such as pre-, ante- and postnatal 
traumas, or a history of asphyxia, non cooperative pupils and children 
of parents who declined to sign the informed consent form, were 
excluded from research participation. Also subjects with a clinical 
suspicion of Down Syndrome. 
 
III.2.2.3 Subject selection 
The individuals were selected based on the medical records obtained 
from the schools.  
 
III.2.2.4. Clinical examination 
Pupils were examined physically by thorough clinical examination 
using a protocol adapted from the RUNMC. Subsequently photographs 
were taken from all examined pupils. 
 
III.2.2.5 Sample collection 
After clinical examination 5 mL heparinized blood (for chromosome 
analysis) and 5-10 mL EDTA blood (for DNA analysis) were drawn 
from each individual. 
 17
III.2.2.6 Minimum sample required 
 Research with single samples in a large population has never been 
performed in Indonesia before; therefore we used the following 
formula to determine the minimum required amount of samples38 
 
    
 
 
 
            P=0,50; Zα= 1,96; d=0,10 
     
         n= (1,96)2 x 0,50 x (1-0,50) = 96 
      (0,10) 2 
    
III.3. Methods 
  III.3.1 General 
Parents of pupils who met our selection criteria were asked to 
join the research project by signing written informed consent 
forms. Blood samples were drawn from the individuals as 
described in section III.2.2.5. Parents were also informed that, 
if an abnormality was found in their child, they would be 
requested for blood sampling. 
  III.3.2. Laboratory Methods  
III.3.2.1 Chromosome analysis 
              Chromosome preparation was made by culturing  10 
drops of heparinized blood into two different 5 ml media 
(TC199 and MEM), each supplemented with 5 % Fetal Bovine 
Serum (FBS) and 0,025 mL Phytohemaglutinin-P (Gibco) in 
37oC for 72 hours. In a MEM media tube 0,1 mL thymidine 
(final concentration of 0,3 µg/mL) and 3 drops of colchicine 
n = Zα2 PQ 
d2 
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(concentration of 1 µg/mL) were added and incubated for 24 
hours and 25 minutes before cell harvesting. A TC199 tube was 
treated with colchicine (concentration of 1 µg/mL) but without 
thymidine. After the culture process was finished, the culture 
tube was centrifuged at 1000 rpm for 10 minutes and the 
supernatant was removed. A warm (37oC ) hypotonic solution 
KCl 0,075M was added to the cell pellet and then resuspended 
until homogeneous and subsequently incubated at 37oC in a 
waterbath for 15-30 minutes. Thereafter the cell suspension 
was centrifuged at 1000 rpm for 10 minutes, the supernatant 
was removed and 5 mL Carnoy’s solution (3:1 methanol: acetic 
acid glacial) was added slowly through the tube wall, and 
shaken well. These steps were repeated constantly until a clear 
precipitation was obtained. After a clear precipitation was 
obtained, then fresh Carnoy’s solution was added to suspended 
residues. Subsequently, two drops of cell suspension were 
released onto a glass slide from a height of around 20 cm39.  
 Finally, the slides were stored for approximately 3 
days. After that, the aged slides were rinsed with water and put 
into warm Hanks solution (37oC),  put into trypsin 0,1% (in 
warm Hanks buffer) for 10-25 seconds, depending on the 
sensitivity and slide age, and again rinsed with water. 
Thereafter the slide was flooded with Giemsa 10 % staining in 
buffer phosphate PH 6,8 for 1 minute (for GTG Banding 
staining). 
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  III.3.2.2. DNA isolation 
DNA was isolated with a salt saturation method: 
EDTA frozen blood was transferred into a 50 mL tube. NH4Cl 
5-10 ml lysis buffer was added to the tube and incubated for 10 
– 30 minutes at room temperature. Then the tube was 
centrifuged for 5 minutes at 3000-3500 RPM, the supernatant 
was removed and NH4Cl lysis buffer was added again. These 
steps were repeated three times. Two mililiters of TE lysis 
buffer, Proteinase-K 10mg/mL and 100 ul 10% SDS were 
added and mixed gently into a white pellet and then incubated 
at 50oC for 24 hours. Subsequently NaCl 6M approximately 
one third volume of the tube  was added to the suspension  and 
centrifuged at 4000 RPM for 10 minutes. New tubes were used 
for the supernatant and absolute ethanol twice volume 
supernatant was added. DNA that looked like white substance 
was removed by fine needle. After that, DNA was rinsed with 
70 % ethanol and transferred into a 1,5 ml tube. Excess ethanol 
was evaporated by leaving the tube open for at least 1 hour. 
Then the DNA was dissolved into TE buffer39,40. 
III.3.2.3.1.  FMR-1 gene amplification 
   Brief method description: 
 CGG repeats in FMR-1 were amplified with PCR 
technique. Subsequently PCR products were electrophoresed in 
agarose gel together with specific marker to determine the 
length of amplified DNA41 
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Procedures: 
Approximately 100 nanogram DNA solution was 
amplified in a final volume of 20µl mix solution containing 2µl 
10x PFX buffer, 0,6 µl MgSO4, 0,5µl dNTP’s, 8,0 µl PCR 
enhancer solution, 0,6 µL forward (gct cag ctc cgt ttc ggt ttc 
act tcc ggt) and reverse primer (agc ccc gca ctt cca cca cca gct 
cct cca) FAM labelled42, and 0,3 uL Platinum Taq enzyme and 
6,4 milliQ. The samples were denatured initially for 5 min at 
95°C followed by 31 cycles of 95°C for 15 seconds, 64°C for 2 
min; 72°C for 2 min with a final extension of 7 min at 72°C. 
Thirty uL Ethydium bromide 0,5% was added to the 300 ml 
agarose gel in  and 60 uL was added to the TBE buffer. PCR 
products were electrophoresed in a 2 % agarose gel at 120 Volt 
for 3 hours with a 100 bp marker. A picture of the 
electrophoresed gel was visualized with IMAGO UV image 
processing. A normal CGG repeat will be between 3-55 
repeats. Male samples that not produced PCR product were 
repeated two times. Southern Blot Analysis were performed on 
those samples that still not produced PCR product (after 
repeated two times), samples with high CGG repeat and woman 
with single allele (can be homozygous samples or normal and 
expanded allele)  
 
III.3.2.3.2 Fragment Length Analysis for FMR-1 gene 
(genescan) 
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Brief method description: 
Fragment length analysis was used to determine the length of 
CGG repeat accurately. This method can be used to detect 
fluorescent labeled DNA fragments based on its length 
precisely.  
Procedures: 
Reverse primer with fluorescent dye (FAM) was used in 
the PCR process. PCR products were mixed with LIZ 500 size 
standard marker and formamide and subsequently sent to the 
ABI 3730 machine to measure the CGG repeats. One µl PCR 
product was mixed in a final volume of 10 uL mix solution 
containing 8,7 uL formamide and 0,3 uL LIZ 500 standard size 
marker. Raw data from ABI 3730 were analyzed using 
Genemapper Software version 4.0 (Apache Software). 
Fragment length analysis was performed with known CGG 
fragments both in normal control and premutation control. 
III.3.2.3.3 Southern Blot Analysis 
Brief method description: 
Southern blot was used to confirm the CGG  results of male 
samples, without an FMR-1 PCR and female samples that only 
showed a single allele (homozygote samples or normal and 
expanded allele). 
DNA was digested using double digestion method for 
methylation studies with HindIII and Eag I restriction 
endonuclease enzyme to demonstrate methylation pattern. 
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Normal fragment size will be 2,8 Kb for EagI and 5,2 Kb for 
HindIII respectively. Recognition site for HindIII  is (5’ 
A*AGCTT; 3’ TTCGA*A) and EagI (5’ C*GGCCG; 3’ 
GCCGG*C) respectively. Using a methylation sensitive 
enzyme allows us to distinguish between methylated and 
unmethylated FMR1 alleles. Normal samples will be showed 
clear band of 2,8 Kb relating to unmethylated normal allele and 
5,2 Kb reflecting methylated normal allele due to X-
inactivation process respectively. Premutation allele will be 
shown higher band above 2,8 Kb in permutation range. Full 
mutation allele will be shown an expanded allele above 5,2 Kb. 
Premutation allele and full mutation allele are unstable, 
therefore these allele sometimes might be identified as a smear. 
The fragmented DNA was electrophoresed in agarose gel. 
Afterward fragmented DNA in the agarose gel was transferred 
into nylon membrane. Then DNA was denatured with alkali 
and fixed into membrane using UV-crosslink apparatus. 
Subsequently single-stranded DNA was hybridized with probe 
pAO365 (tc gag cgc ccg cag ccc acc) and specific labeled 
radioactive (32P)43. Sequences of the probe in the FMR-1 gene 
are described below this section. Then X-ray film was used to 
develop the signal from hybridized DNA41.  
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TACACCCGCA GCGGGCCGGG GGTTCGGCCT CAGTCAGGCG CTCAGCTCCG  
     Primer Forward 
TTTCGGTTTC ACTTCCGGTG GAGGGCCGCC TCTGAGCGGG CGGCGGGCCG 
 
ACGGCGAGCG CGGGCGGCGG CGGTGACGGA GGCGCCGCTG CCAGGGGGCG  
 
TGCGGCAGCG CGGCGGCGGC GGCGGCGGCG GCGGCGGCGG AGGCGGCGGC  
 
GGCGGCGGCG GCGGCGGCGG CTGGGCCTCG AGCGCCCGCA GCCCACCTCT  
      Probe Sequence 
CGGGGGCGGG CTCCCGGCGC TAGCAGGGCT GAAGAGAAGA TGGAGGAGCT  
      Primer 
GGTGGTGGAA GTGCGGGGCT CCAATGGCGC TTTCTACAAG GTACTTGGCT  
Reverse 
146801150 
 
146801200 
 
146801250 
 
146801300 
 
146801350 
 
146801400 
 
146801450 
 
Figure 1. Sequence of FMR1 gene  
Sequence of FMR-1 gene showed the location of both primers (Bold and underlined) 
and sequence of pAO365 probe (Underlined) and the CGG repeats sequence (bold 
and italic) 
 
 
Procedures: 
DNA Digestion 
Seven ug DNA (in 35 uL diluted solution with milliQ) was 
digested with restriction endonuclease enzyme (1,25 uL Hind 
III and 1,5 uL Eag I) in the buffer React H together with 20 
mM Spermidine in a total volume of 15,75 uL for a minimum 5 
hours at 37°C. 
Electrophoresis 
Five uL loading buffer (bromophenol blue) was added  to 
Digested DNA and subsequently 50 uL was loaded per well. 
Thirty uL  of 0,5% ethydium bromide was added to the buffer.  
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Electrophoresis of DNA was performed 16 hours (overnight) in 
a 0,8% agarose gel  at 38 volt in TAE buffer. 
DNA transfer 
DNA in agarose gel was transferred into nylon membrane 
(Genescreen Plus Perkin Elmer) using a 0,4N NaOH+NaCl 
buffer solution for capillary blotting using filter membrane, 
paper stack and weighing mass (~ 500 grams) above the 
membrane for five hours. Then, the nylon membrane was 
washed in the phosphate buffer, dried and cross-linked into a 
1200 UV Stratalinker. 
Radioactive labeling 
Labelling beads were prepared by adding a tube Ready-To-Go 
DNA labelling beads (-dCTP) (Amersham) to 20 uL of water 
and incubating this solution for 5-60 minutes on ice. In the 
meanwhile the probe mix (pAO365) was denaturated at 95°C 
for 5 minutes. Thereafter the Probe-mix was mixed with the 
labelling beads and 2,5 uL (alpha-32-P-dCTP) was added for 
incubation overnight.  A sephadex G-50 column was used to 
purify the labelled probe. Oligonucleotide labelling products 
were denatured at 95 °C for 5 minutes. The oligonucleotide 
labelling products were added to a hybridization buffer. 
Hybridization was performed overnight at 65 °C. Tough 
cleaning was performed in 0,1 % SDS + phosphate buffer twice 
at 65°C for 5 minutes and once at 65 °C for 20 minutes. And 
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finally only phosphate buffer was used to end the washing 
procedures.  
Autoradiogram 
Autoradiography was performed on X-ray film (Kodak ECL) 
for 1-3 days at -80 °C using intensifications screens. 
III.3.2.4. Multiplex Ligation-Dependent Probe 
Amplification (MLPA) 
Brief method description: 
MLPA is a new method for relative quantification of about 40 
different DNA sequences in an easy to perform reaction. This 
technique has been developed and first described by MRC-
Holland40. The different steps of MLPA are: DNA 
denaturation, hybridization of the DNA sample with a specific 
probe, ligation of the hybridized probe with a thermostable 
ligation and finally a PCR reaction is used to amplify the probe. 
III.3.2.4.1 Sub-telomeric duplication and deletion (STD) 
analysis using MLPA technique (P070 probe-kit) 
Brief method description: 
To detect STDs in samples, P070 probe-kit was used. P070 
probe-kit contains one probe for each subtelomeric region from 
chromosome 1-22 and the two X/Y pseudo autosomal regions 
(PAR). For acrocentric chromosomes (13, 14, 15, 21 and 22) 
the probe for p-arm are located in the q-arm close to the 
centromere (Figure.2) 
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  Procedures: 
Denaturation 
Approximately 200 ng DNA samples in 5 uL were denatured at 
98 ºC for 5 minutes followed by cooling to 25 ºC.  
Hybridization 
One and half micro liter probe-mix mixtures were added to the 
denatured DNA at 25 ºC and  heated for 1 minute at 95 ºC 
followed by incubation at 60 ºC overnight. The probe-mix 
consisted of : 1,5 uL SALSA probemix (probe number P070) 
and probemix buffer (MRC-Holland).  
Ligation 
Figure 2. Probe locations in each chromosome.  
Red block represent probe in autosome and yellow block represent probe in sex 
chromosome (probe in the Pseudo Autosomal Region/ PAR) 
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After overnight incubation, the temperature was reduced to 54 
ºC and in the meanwhile ligase-mix consisting of 3 µl Ligase-
65   buffer A (transparent cap), 3 µl Ligase-65 buffer B (white 
cap), 25 µl milliQ and 1 µl Ligase-65 (brown cap) was added to 
the hybridized probes. This was followed by incubation of 15 
minutes at 54 ºC and after that heated for 5 minutes at 98 ºC.  
Amplification 
Five uL ligated DNA was  amplified in a final volume of 25 uL 
PCR solution containing 2 uL PCR buffer, 1 uL enzyme buffer, 
1 uL PCR primers, 0,25 uL Taq Polymerase and 15,75 uL 
milliQ. The PCR conditions were as follows: initial 
denaturation at 97 ºC for 1 minute followed by 35 cycles: 30 
seconds 95 ºC; 30 seconds 60 ºC; 60 seconds 72 ºC and ended 
with 20 minutes incubation at 72 ºC. 
Analysis 
PCR products were mixed with LIZ 500 size standard marker 
and formamide and sent to the ABI 3730 machine to perform 
probe quantification. One uL PCR product was mixed in a final 
volume of 10 uL mix solution containing 8,7 uL formamide 
and 0,3 uL LIZ 500 standard size marker12. Raw data from ABI 
3730XL were analyzed using Genemapper Software version 
4.0 (Apache Software). Subsequently the results from 
genemapper were imported and analyzed using a specific 
template for each probe developed in Microsoft Excel 2007. 
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III.3.2.4.2 Prader-Willi/Angelman Syndrome analysis using 
methylated specific MLPA technique (P028 Probe-kit) 
Brief method decription 
To detect PW/AS in the samples P028 methylathion specific 
probe-kit was used. This probe-kit contains probes in the 
PW/AS region. In contrast with other MLPA methods, in the 
ligation procedure each sample was separated into two new 
tubes. In the new tube one tube was added with restriction 
enzyme (Hha-1) and another tube without restriction enzyme. 
Procedures: 
Denaturation 
Approximately 200 ng DNA samples in 5 uL were denatured at 
98 ºC for 5 minutes and followed by cooling until 25 ºC.  
Hybridization 
One and half micro liter probe-mix mixtures were added to the 
denatured DNA at 25 ºC and heated for 1 minutes at 95 ºC 
followed by incubation at 60 ºC overnight. The probe-mix 
consisted of: 1,5 uL SALSA probemix (probe number me028) 
and probemix buffer (MRC-Holland).  
Ligation, splitting and digestion with restriction enzyme 
After overnight incubation, the temperature was reduced to 49 
ºC and meanwhile hybridized probe were added with ligase-
mix that consisting of the 3 µl Ligase-65  (MRC-Holland) 
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buffer A (transparent cap) and 10 ul milliQ then solution were 
divided into two different tubes each tube consisting 10 uL 
solution. For first tube were added with 1,5 µl Ligase-65 buffer 
B (white cap), 8,25 µl water and 0,25 µl Ligase-65 (brown cap) 
whilst second tube were added with 1,5 µl Ligase-65 buffer B 
(white cap), 7,75 µl milliQ, 0,25 µl Ligase-65 (brown cap) and 
0,5 uL Hha-1 restriction enzyme (Methylated) this was  
followed with incubation for 30 minutes at 49 ºC, and 
subsequently heated for 5 minutes at 98 ºC.  
Amplification 
Five uL ligated DNA was amplified in final volume of 25 uL 
PCR solution containing 2 uL PCR buffer, 1 uL enzyme buffer, 
1 uL PCR primers, 0,25 uL Taq Polymerase and 15,75 uL 
milliQ.  The PCR conditions were as follows: initial 
denaturation at  72 ºC for 1 minutes followed by 35 cycles: 30 
seconds 95 ºC; 30 seconds 60 ºC; 60 seconds 72 ºC and ended 
with 20 minutes incubation at 72 ºC. 
Analysis 
PCR products were mixed with LIZ 500 size standard markers 
and formamide and sent to the ABI 3730 machine to perform 
probe quantification. One uL PCR product was mixed in a final 
volume of 10 uL mix solution containing 8,7 uL formamide 
and 0,3 uL LIZ 500 standard size. Subsequently the results 
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from genemapper were imported and analyzed using a specific 
template for each probe developed in Microsoft Excel 2007. 
III.3.2.5 DNA purification 
Some DNA samples that could not be analyzed by 
MLPA technique need to be purified. Purification was carried 
out using a QIA cube apparatus. Approximately 10 ng DNA 
was diluted in total 200 uL PBS. To each sample 4 uL of RNA-
ase was added. Subsequently the diluted DNA was purified in a 
QIA cube apparatus as recommended by QIA cube 
manufacture.  
III.3.2.6 Sequencing 
A false positive result might be caused by DNA change 
(polymorphisms or mutations) in the patient’s DNA at the 
location of the probe (So hybridization cannot take place). 
Therefore to exclude this false positive, sequencing of DNA 
surrounding the probe was performed. One uL DNA (~100 ng) 
of each sample was diluted  in a final volume of 15 uL PCR 
mix solution, containing 7,5 uL Fastmix PCR Solution 
(Applied Biosystem), primers for each probe (P070 specific 
location sequence probe) and 6 uL water. The mixture was 
amplified in a Veriti Thermocycler (Applied Biosystem) under 
the scheme of fast PCR by initial denaturation at 95 ºC for one 
minute followed by 35 cycles of 94 ºC, 10 sec; 62 ºC, 25 sec 
and ended with incubation at 72 ºC for 1 minute. The 
sequencing products were purified using Millipore columns as 
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recommended by the manufacturer. The products were dried 
and diluted with 20 uL TE buffer. One and half uL purified 
DNA was mixed with M13 primer forward and reverse. 
Finally, M15 Big terminator Dye (Applied Biosystem) added to 
the diluted sequencing products and analysed on an ABI 3730 
XL sequencer (Applied Biosystem). 
 
III.3.3 Confirmation with another test 
Some results need to be confirmed with another probe-kit. A 
positive result of STD analysis using probe P070 were repeated and 
confirmed using probe P036D in The DNA Diagnostic Department 
RUNMC, The Netherlands. Gene locations in each probe are described 
in Table 3. One sample needs to be confirmed using another probe 
P096 (syndromal kits). Reanalysis with P070 and P036D probe-kit and 
radio-labeling procedures in Southern Blotting Analysis were 
performed by experienced technicians (GS and MRV) following a 
standard operational protocol from the Department of DNA 
Diagnostics of the RUNMC.  
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Table 3. Gene location differences in Probe P070 and P036D 
P070 P036D 
Chromosome Gene location Chromosome Gene location 
1q KIAA1720 1q  KIAA1720  
2q APG4B 2q  CAPN10  
3q KIAA0226 3q  BDH  
4q FRG1 4q  FRG1  
5q GNB2L1 5q  GNB2L1  
6q TBP 6q  PSMB1  
7q VIPR2 7q  VIPR2  
8q RECQL4 8q  KIAA0150  
9q EHMT1 9q  EHMT1  
10q ECHS1 10q  PAO  
11q KIAA1030 11q  KIAA0056  
12q ZNF10 12q  ZNF10  
13q CDC16 13q  F7  
14q MTA1 14q  MTA1  
15q FLJ22604 15q  ALDH1A3  
16q GAS11 16q  GAS11 / GAS8 
17q SECTM1 17q  TBCD  
18q CTDP1 18q  FLJ21172  
19q BC-2 19q  BC-2  
20q FLJ20517 20q  OPRL1  
21q S100B 21q  HMT1  
22q ARSA 22q  RABL2B  
Xq (PAR2) SYBL1 X/Yq  SYBL1  
1p TNFRSF18 1p  SCNN1D  
2p ACP1 2p  ACP1  
3p CHL1 3p  CHL1  
4p ZNF141 4p  FLJ20265  
5p LOC133957 5p  PDCD6  
6p IRF4 6p  IRF4  
7p UNC84A 7p  CENTA1  
8p FBXO25 8p  FBXO25  
9p FLJ00026 9p  DMRT1  
10p BS69 10p  KIAA0934  
11p BET1L 11p  RIC-8  
12p RBBP2 12p  SLC6A12  
“13p” PSPC1 “13p”  PSPC1  
“14p” ADPRTL2 “14p”  HEI10  
“15p” NDN “15p”  MKRN3  
16p DECR2 16p  POLR3K  
17p RPH3AL 17p  RPH3AL  
18p THOC1 18p  USP14  
19p PPAP2C 19p  CDC34  
20p FLJ22115 20p  SOX12  
“21p” STCH “21p”  RBM11  
“22p” IL17R “22p”  BID  
Xp (PAR1) SHOX X/Yp  SHOX  
For acrocentric chromosomes (13, 14, 15, 21 and 22) the probe for p-arm are located 
in the q-arm close to the centromere Gene location for each probe available in MRC-
Holland website (www.mrc-holland.com) 
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III.4 Research Scheme 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
III. 5. Variables 
- Clinical sign of Mental Retardation (Dysmorphology) 
Scale : Nominal 
- Cytogenetics and molecular assessment result 
Scale : Nominal 
 
III.6. Operational definitions: 
1. Clinical signs (phenotype / dysmorphology) : All clinical features that occur 
together with the MR  
2. Genetic assessment result: all chromosomal rearrangements or gene mutations 
that cause MR 
Genetic Assessment 
/ Analysis
Parent signed 
Informed Consent
Pupil eligible with 
AAMR criteria 
Photograph taking 
Confirmation test 
in case genetic 
abnormality was 
found 
History taking and 
physical examination
Blood sampling 
Data Collection 
from School 
Seminar for Parents 
and teachers 
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3. Mental Retardation criteria (AAMR)8: 
i. Substantial limitations in present functioning 
(subaverage intellectual functioning i.e IQ < 70) 
ii. Limitations in two or more of the following applicable 
adaptive skill areas: communication, self-care, home 
living, social skills, community use, self-direction, 
health and safety, functional academics, leisure and 
work.  
iii. The  age of onset should be before age 188 
 
4. Level of Mental retardation8: 
Class IQ 
Profound mental retardation Below 20 
Severe mental retardation 20–34 
Moderate mental retardation 35–49 
Mild mental retardation 50–69 
Borderline mental retardation 70–79 
 
III.7 Collected Data 
III.7.1 Primary Data: 
1. Personal identity of each mentally retarded subject, including date of birth, 
sex, ante-natal care, pre-natal care and family tree (pedigree).  
2. Data on clinical signs of the individuals. These data were obtained according a 
diagnosis protocol check list. 
 
III.7.2 Secondary data: 
Medical records which were obtained before the pupils entered special school 
(IQ etc). 
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III. 8. Data Analysis: 
Data will be analyzed with descriptive method then data will be presented in 
tables and graphics.   
CHAPTER IV 
RESULTS 
 
From 186 pupils selected in three special schools, only 122 pupils can be 
included in further analysis based on the inclusion and exclusion criteria.  A total 
of 122 samples were obtained from subjects with mental retardation from three 
special schools in Semarang as indicated in Table 4. Cytogenetic preparations 
were carried out in all samples. All samples were screened for CGG repeats in the 
FMR-1 gene. Eleven samples (9 females with single alleles and 2 males; 1 with 
absence or a PCR product and 1 with high CGG repeat) had to be confirmed by 
southern blot.  
Of the 122 samples, 121 were suitable for sub-telomeric deletion and 
duplication studies (STDs) with MLPA analysis, whereas 1 sample was excluded 
based on the FMR-1 analysis results. However, one sample cannot be analyzed 
using MLPA analysis due to bad DNA 
Of these 107 samples (1 sample was excluded based on FMR-1 result, 1 
sample due to Down Syndrome and 13 based on STDs analysis), 13 were selected 
for Prader-Willi/Angelman syndrome (PW/AS) study. This selection was based 
on the phenotypic features of the patients. 
 
IV.1. FMR-1 Analysis 
A total of 122 subjects with developmental disability from three special 
schools in Semarang were analyzed for trinucleotides repeats expansion (PCR 
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Analysis on agarose and genescan). To determine exact number of CGG repeats, 
PCR products were analyzed by Fragment Length Analysis (genescan). Southern 
Blotting was used when the PCR / Fragment Length Analysis were not clear; 
there was no PCR product in agarose gel (1 sample), or when the CGG repeats 
were too high (1 sample) and when single allele (can be homozygous samples or 
normal and expanded allele) found in woman samples (9 Samples). Southern Blot 
analysis was performed in those samples which identified one subject with a full 
CGG expansion, one subject with a mosaic pattern (premutation and full 
mutation) and none of the females were found to have a CGG expansion. The 
FMR-1 CGG repeat sizes of screened subjects are depicted in Table 5 while the 
results of Southern Blotting are illustrated in Table 6. Furthermore the graphic of 
the repeat sizes in screened subject by PCR analysis for FMR-1 (genescan result) 
is depicted in Figure 3. 
 
Table 5. CGG repeat sizes in subjects screened by FMR-1 Analysis 
CGG Repeat Male Female *) 
15-35 80 24
36-55 12 4
56-200 1 -
> 200 1 -
 *) In female samples only the highest repeat allele was counted.  
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Table 6. Results of molecular analysis 
No. Pupil ID Sex PCR result Southern Blot Result 
1. SM-30C M No product > 5,2 Kb 
2. SM-34C M High CGG Repeat  > 2,8 Kb ~ > 5,2 Kb 
3. SM-20 F Single allele 2,8 Kb & 5,2 Kb 
4. SM-37C F Single allele 2,8 Kb & 5,2 Kb 
5. SM-26 F Single allele 2,8 Kb & 5,2 Kb 
6. SM-36C F Single allele 2,8 Kb & 5,2 Kb 
7. N-52 F Single allele 2,8 Kb & 5,2 Kb 
8. N-54 F Single allele 2,8 Kb & 5,2 Kb 
9. N-61 F Single allele 2,8 Kb & 5,2 Kb 
10. PI-19 F Single allele 2,8 Kb & 5,2 Kb 
11. PI-21 F Single allele 2,8 Kb & 5,2 Kb 
 
Figure 3. Distribution of CGG repeats among all subjects. 
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This study showed, an allele with 29 CGG repeats is the most frequent one in this 
population followed by 28,30,35 & 36 CGG repeats as illustrated in Figure 2.  
 
IV.2.STDs Analysis with MLPA technique 
To identify sub-telomeric deletions and duplications (STDs) analysis by 
MLPA was carried out. One male was excluded for STDs analysis because of a 
positive FMR-1 result. However one sample cannot be analyzed using MLPA 
analysis due to bad DNA. Therefore 120 samples were tested with MLPA 
analysis. The initial screening with the P070 kit (MRCH) which contains probes 
in all telomeric regions of the different chromosomes showed 13 samples with 
subtelomeric rearrangements as indicated in Table 7. Re-analysis using another 
probe-set (P036D) by DNA Diagnostic RUNMC confirmed that 8 out of 13 
indeed had a sub-telomeric rearrangement. One sample was excluded from further 
analysis after the result of MLPA was confirmed with cytogenetics showing 
trisomy 21 (Down syndrome). Three samples that did not showed same aberration 
by confirmation with P036D probe were considered most likely because of 
polymorphism but it still could be something (very small deletion / duplication) 
and it will be discussed in the next chapter. The results of STDs analysis using 
MLPA technique are shown in Table 7. 
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Table 7 Sub-telomeric deletions and duplications found in subjects by STDs 
MLPA Analysis using P070 kit 
No. Subject ID Sex Aberration(s) P036D 
performed? 
Result 
1 N-10 / ID 153 M Del 4pter / dup 8pter  Yes 1) Confirmed 
2. PI-14 / ID 207 M Dup 2pter Yes Confirmed 
3 PI-22 / ID 398 F Del 18pter Yes Confirmed 
4 N-26 / ID 169 M Dup 16qter Yes Confirmed 
5 N-55 / ID 386 F Del 10pter / dup 9pter Yes Confirmed 
6 SM-36C / ID 419 F Del 18 pter/ dup 4pter  Yes Confirmed 
7 N-47 / ID 190 M Dup 9pter Yes Confirmed 
8 P1-24 / ID 400 M Del XYqter No (P070 twice) P036D not 
performed  
9 N-38 / ID181 M del4qter/dup10qter Yes 2) Not confirmed 
10 N-18 / ID 161 M del4qter/dup10qter Yes 2) Not confirmed 
11. N-34 / ID 177 M Dup 21 pter/qter No (Cytogenetic) Confirmed 4) 
12 N-39 / ID 182 M Dup 10pter Yes 3) Not confirmed 
13 N-30 / ID 173 M Dup 10qter Yes 3) Not confirmed 
 
 
1) Confirmed with P096 kit (syndromatic kit) and sequencing also 
2) Samples analyzed with P036D first and confirmed with P070 
(The other way around) 
3) Artificial result cannot be excluded 
4) Trisomy 21 
 
IV.3. PW/AS Analysis with MLPA Technique 
Thirteen samples from a total of 106 subjects were selected to be analyzed 
for PW/AS syndrome using the P028 kit (MRCH). Selection was based on clinical 
examination criteria for PWS/AS. No positive result was detected in the samples 
both in the methylated and unmethylated probes. 
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IV.4. Clinical findings 
Before the molecular analyses were carried out, clinical examination had 
been performed in all subjects. These were performed using a standardized 
protocol adapted from the RUNMC. Height, length and OFC were measured and 
dysmorphisms were described. In male subjects testicular size was measured 
using a comparative palpation method with the Prader orchidometer. The 
phenotypic features of all subjects with a proven genetic abnormality are 
presented in Table 8 and the clinical photographs of various subjects with sub-
telomeric rearrangements are presented in Figure 4.  
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Table 8. Summary of Dysmorphological features  
 45Table 8. Summary of Dysmorphological features (Continued) 
 46Table 8. Summary of Dysmorphological features (Continued) 
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IV.5 FMR-1 analysis of a family with a full mutation. 
The family of the proband with a full CGG expansion was visited and 
blood samples were taken from all family members in order to detect carriers and 
possibly affected individuals. FMR-1 gene analysis including Fragment Length 
Analysis and Southern Blot were performed in all family members as shown in 
the pedigree in Figure 5. The FMR-1 analysis results are illustrated in Table 9. 
 
Figure 5.  Pedigree of affected Fragile-X family (SM-30C) 
 
 
 
 
 
II:1 
I:1 I:2 
II:2 II:3 II:4 II:5 II:6 
 
 
Premutation FMR-1 gene 
Mental retardation 
Mosaic premutation FMR-1 gene 
Full mutation FMR-1 gene 
Learning difficulties 
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Table 9. FMR-1 test in family members from subject with full CGG repeat 
expansion (subject II:3/SM-30C) 
Subject ID Pedigree  
code 
Sex CGG 
Repeat 
Remarks 
ID 572 I:1 M 26 Normal 
ID 573 I:2 F 29/69 Premutation carrier 
ID 574 II:1 F 26/86 Premutation carrier  
ID 575 II:2 M 86-103 Mosaic permutation carrier 
ID 413  II:3 M >200 Full mutation (Tested before / 
SM-30C) 
ID 576 II:4 M 80-103 Mosaic permutation carrier 
ID 577 II:5 F 26/ 29 Normal alleles 
ID 578 II:6 F 26/>200 Full mutation  
 
Several carrier females were identified in this family; the mother (1:2) had 
a normal allele and an elevated band size in PCR amplification which was 
confirmed by Fragment Length Analysis and Southern Blot. The first daughter 
(II:1) had 1 normal allele and 1 allele in the premutation range. Two brothers (II:2 
and II:4) of the proband had a mosaic premutation allele which was assessed by 
PCR and fragment length analysis and confirmed by Southern Blot. The second 
daughter (II:5) had normal alleles. The youngest daughter (II:6) showed 1 normal 
allele and 1 fully expanded allele which was assessed by Southern Blot. Except 
for the affected proband all sibs and the carrier mother apparently had a normal 
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intelligence.  However, one male (II:4) had  learning difficulties which will be 
discussed in the next chapter. 
 
IV.6 Cytogenetic Analysis 
Cytogenetic preparations were carried out in all samples; One sample with 
trisomy 21 was detected, two with structural abnormalities and the others showed 
normal karyotype. The complete result of cytogenetics analysis showed in the 
appendix section. 
 
Table 10. Results of cytogenetics analysis 
No. Subject 
ID 
Sex Karyotype 
1. N-34 M 47,XY+21 
2. N-10 M 46,XY,del(4)(p16) 
3. PI-14 M 46,XY,add (2)(p25) 
 
 
 
CHAPTER V 
DISCUSSION 
 
The purpose of this study was to identify the major genetic causes of 
mental retardation in Indonesia and to establish its prevalence. The study was 
conducted in 1.5 year and the subjects were tested for microscopic visible 
chromosomal aberrations, sub-telomeric deletions and duplications, Fragile X 
syndrome, Prader-Willi and Angelman syndrome. In addition, the results of this 
research project should raise the level of awareness in the Indonesian community, 
especially within the medical society particularly among clinicians.  
Many factors, such as economic factors, parental education and a low 
awareness, may lead to a failure in registering mentally retarded children at 
special schools. This may have led to an ascertainment bias in selecting the 
individuals for this study because the total number of subjects that were registered 
at special schools might not have represented the total number of persons with 
mental retardation in Indonesia. 
The molecular identification of most major causes of mental retardation 
had to be performed abroad because of the lack of laboratory facilities in 
Indonesia. To resolve this issue, this part of the project was done in the RUNMC 
in the Netherlands. 
Finally, it has to be taken into account that, due to financial and time 
constraint, the progress of this research was not as smooth as it was planned to be. 
Sometimes the different steps of the research project were performed within 
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inappropriate order. For instance, one trisomy 21 subject was identified by MLPA 
before it was confirmed by regular cytogenetic analysis. 
 
V. 1. Fragile-X Syndrome (FXS) 
The finding of a sample with a CGG expansion confirmed that FXS is one 
of the causes of mental retardation in the Indonesian population. Based on the 
results of this research, the prevalence of FXS in this population is 0,82 % (1/121) 
and 1,07% (1/93) among the male part of the Indonesian inhabitants respectively 
(Down syndrome case was excluded from calculation). Possibly, the prevalence 
was higher because there was another subject with a mosaic pattern of a pre-
mutation and a full mutation. Rousseau et al. (1994) observed no significant 
mental status difference between subjects with a mosaic mutation pattern and a 
full mutation45. Based on that study this subject with mosaicism should also be 
included in counting the prevalence of FXS. If so, the prevalence would be 1,65% 
(2/121) in the total Indonesian population and 2,15% (2/93) in the male 
population. Previous research by Faradz et al. (1999) showed a lower FXS 
prevalence of 1.9 % (5/262) in the male population5. This lower prevalence might 
have been produced because a larger number of samples were used in Faradz’s 
study.  
 
V.1.1. Clinical findings of subject with CGG expansion 
One subject with a full expansion of the CGG repeat had major clinical 
sign of FXS i.e. mental retardation, shyness behavior, a long face, a pointed chin, 
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long fingers and macroorchidism. However he did not have macrocephaly, loose 
joints, and a soft stretchy skin which are major physical features of FXS 46. In 
addition, he also did not have large and prominent ears which is one of the classic 
triad of Fragile-X Syndrome.  
One subject with a mosaic pattern of a premutation to a full mutation was 
identified. During clinical assessment he was noted with shy behavior, a long and 
narrow face and large and prominent ears. He had two out of three classic features 
of FXS.  Regardless of the fact that mosaic FXS males still produce FMR protein, 
they are nevertheless developmentally delayed 45.  
One explanation could be that the amount of FMR-1 protein present in the 
brain is insufficient to permit normal development. Furthermore in the Southern 
Blot analysis of this subject was showed that full mutation allele was more 
dominant than premutation allele. Nevertheless Cohen et al. (1996) observed that 
mosaic males had a 2-4 times higher rate of adaptive skills than non-mosaic 
Fragile-X males47. Unfortunately we did not test the adaptive skills of our subjects 
yet.  
 V.1.2. Fragile-X in a family 
Premutation alleles are not thought to be associated with clinical effects in 
the majority of the premutation carriers. However, some studies have suggested 
that a small proportion of the premutation carriers may have some behavioral, 
physical or cognitive features 48,49. Furthermore premature ovarian failure (POF) 
was reported in about 20 % of the premutation carriers. Allingham-Hawkins et al 
Jacquemont et al, and Hagerman et al, also reported progressive intention tremors 
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and cerebellar ataxia in several male premutation carriers above the 50 years of 
age, called Fragile-X associated Tremor Ataxia Syndrome (FXTAS) 50-53. 
In addition, all premutation carriers are at risk to get FXS affected 
children. The chance that a female permutation carrier passes the X chromosome, 
with the fragile X permutation, over to each of her offspring is 50%. Since the 
trinucleotide repeats can expand upon transmission from a carrier female to her 
male offspring, her sons are at risk to inherit an expanded CGG mutation and 
subsequently to be affected by FXS 46. 
The affected family described in this study is a perfect example to 
illustrate the X-linked inheritance of FXS. The mother had a premutation allele 
which was transmitted to almost all of her offspring, except for her second 
daughter who inherited her normal X chromosome. Interestingly, all offspring 
who inherited the affected allele had various repeat lengths varying from a 
premutation allele, a mosaic pattern within the range of premutation and a full 
mutation.  
Two sons in this family also had a premutation mosaic pattern. All mosaic 
patterns were still in the premutation range in contrast with previous case with 
mosaic between premutation to full mutation. Thus the result has no consequences 
to their mental status. However, in fact one son has a premutation mosaic pattern 
developed learning disability. It is suggested that his learning disabilities was not 
due to his premutation allele.  Furthermore to confirm this, FMRP studies is 
needed to evaluate the FMRP product. 
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It will be valuable to trace back all premutation carriers as far as possible 
in the previous generations to determine which persons in the family are at risk to 
produce affected offspring and to monitor the older premutation carriers for 
FXTAS (in male carriers) and POF (in female carriers). Family members should 
be aware of the X-linked inheritance pattern and they should be advised to take 
the test to determine carriership. In this case it was not possible to trace the 
premutation back to another generation because both parents of the mother who 
might have had a premutation were not available.  
Genetic counseling should be provided to this family. The first daughter, 
with a premutation allele, is at risk to transmit the affected allele to the next 
generation. All daughters of the first son, who is also carrying a premutation, will 
be a premutation carrier. The youngest daughter is carrying a full mutation allele 
which means she may develop normally or will have learning disabilities or even 
some degree of mental retardation54-56 
  
V.1.3 Distribution of CGG repeats in this population 
This study showed that an allele with 29 CGG repeats is the most frequent 
one at FRAXA locus in this population. Numerous studies have reported an allele 
with 30 CGG repeats as the most frequent one at the FRAXA locus in Caucasian 
populations, and the 29 CGG repeats initially reported has been considered a 
miscalculation due to differences in C+G content which affect the migration of the 
PCR products 57,58. In the 119 non fragile-X subjects, we identified 15 different 
normal alleles ranging from 15 – 43 CGG repeats as showed in figure 2. In six 
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alleles (28,29,30,35,36) accounted for 75% of the total, and 29 CGG repeats is the 
most frequent one in our study, which is in contrast with Caucasian population 
(the most frequent is 30 CGG repeats)57,58. In Asian population, 29 CGG repeats 
is reported to be the most frequent allele 59,60, although in another study suggested 
that 28 CGG repeats to be the most allele in China 61. Nevertheless this study 
confirmed the similar result with previous study in Indonesian population by 
Faradz et al 6.  
 
V.2. STD’s analyses  
The first results of the Sub-telomeric deletion and duplication (STDs) 
studies in this population confirmed that STDs are a cause of mental retardation in 
the Indonesian population. Phenotypic manifestations of Sub-telomeric 
rearrangements vary and the clinical features depend on the size of the duplication 
and/or the deletion, on the chromosome number(s) affected and the genes located 
in this region. Koolen et al and Rooms et al. suggested that MLPA is a reliable 
method to detect sub-telomeric rearrangements.  However, both studies 
considered the fact that confirmation with FISH is still necessary12,16. 
 Confirmation studies are considered necessary to exclude a polymorphism 
under the probe. However, Nothrop et al. suggested that the strategy of using two 
sets of complementary probe sets would mostly overcome the polymorphism 
problems and this strategy was also conducted in this research project 17. The 
P070 probe-kit was used in the first analysis and subsequently, to confirm 
possible positive results, the P036D probe-kit was used. In general, most of the 
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probe sequences of the P070-kit are located more distal to the telomeric region 
than the probes in the P036D-kit. Therefore, small submicroscopic deletions and 
duplications could still be identified. An example of the sub-telomeric probe 
positions of the two different kits is shown in Figure 6. 
In addition, Nothrop et al. suggested that caution must be applied in 
distinguishing polymorphic from non-polymorphic copy number changes, because 
some deletions or duplications detected by one probe, which were not confirmed 
with another probe, could still be pathogenic17. For instance, if the identified 
deletion or duplication would be located in a known polymorphic region and only 
one probe would detect this abnormality, it might be considered as a 
polymorphism. However, if the aberration would be located in a non-polymorphic 
region it could still be a very small deletion or duplication. As explained before, 
the P070 probes are located more distally in the telomeric region. Therefore, in 
case a sample shows a positive result with the P070 probe, not detected in the 
P036D probe, it might still be a very small deletion in the most distal end of the 
telomere. However, this will not count for all chromosomes as not all P070 probes 
are located in the same gene or more distally in the telomere than the P036D 
probes. Thus, before a conclusion can be made, the location of every probe needs 
to be checked in the genome browser. 
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In addition, Koolen et al. suggested, to exclude polymorphisms, the 
interpretation of the MLPA results should always include parental testing and a 
comparison of the phenotype of the subject with the clinical features of previously 
reported subjects with similar sub-telomeric rearrangements12. Due to technical 
reasons, parental testing could not be carried out in this study. However, it was 
possible to compare the clinical manifestations of some affected subjects with 
previously reported subjects with similar sub-telomeric rearrangements. In the 
following sections the clinical presentation of these subjects will be compared to 
the information available in literature and in chromosomal aberration databases.  
 
V2.1 Subject 1 (Del 4pter/Dup 8pter)  
Figure 6. The probe location of P070 and P036D in the telomeric region of chromosome 
10p  (Adopted from the UCSC genome browser, Hg 19:http://genome.ucsc.edu/) 
 
 58
 Deletions of chromosome 4pter are well known and cause the 
characteristics of the Wolf-Hirschorn Syndrome (WHS). The WHS Critical 
Region (WHSCR) is located on 4p16.3 11. Deletions with a size less than 3.5 Mb 
have been described by Zollino et al. and resulted in a distinct but relatively mild 
WHS62. In Subject 1 the P096 probe was used to investigate the size of the 
WHSCR deletion which showed a deletion of the whole WHSCR (Figure 7). 
WHS is associated with a characteristic face comprising wide mouth, short upper 
lip with flat philtrum, beaked nose, prominent eyes, telecanthus, slanted palpebral 
fissures and maxillary hypoplasia, MR, hypotonia, growth retardation and 
microcephaly 62,63. In addition to the 4pter deletion, 8pter duplication was also 
detected, which implies that this subject may have some characteristics of 
duplication 8pter. However, duplications of segment 8pter are associated with 
mild mental retardation only without typical dysmorphic features64,65. He had 
growth retardation, microcephaly, hypotonia and some WHS facial 
characteristics. A clinical summary of this subject is shown in Table 8. Therefore 
we conclude that almost all clinical manifestations in this Subject are caused by a 
terminal deletion of chromosome 4p. The phenotypic features of this subject were 
suggestive of WHS which was confirmed by MLPA analysis using probe P070, 
P036D, and P096. Since a duplication of chromosome 8p does not lead to a 
distinct phenotype and because it is difficult to confirm either by MLPA or FISH 
it is suggested if this subject indeed has 8pter duplication also. Due to the 
presence both of deletion and duplication in this subject, unbalanced translocation 
is thought. Therefore cytogenetic result is needed to confirm microscopically 
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visible unbalanced translocation (to see whether it is present or not), however in 
the cytogenetic analysis only deletion of 4p16 was detected [This subject has 
karyotype of 46,XY,del(4)(p16)] . We suggest that duplication of 8pter is very 
small, thus FISH and or array is needed for further assessment. In addition, 
parental testing is needed to trace the balanced translocation in the parent.  
 
 
 
 
 
 
 
 
 
 
 
Figure 7. MLPA result using p096 probe-kits (Syndromatic kits) of subject 
N-10 
Deletion of whole WHSCR region (4p16.3) is identified in this subject sample 
using MLPA with probe-kits P096. 
 
V.2.2. Subject 2 (Dup 2pter)  
 Wakita et al. reported a subject with a duplication of 2p25.1-25.3 with a 
minimal phenotype. The phenotypic features included hypertelorism, an abnormal 
shape and position of the ears and long and hyperextensible fingers 66. However, 
Deletion of 
whole WHSCR 
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Al-Saffar et al. reported a larger terminal duplication of 2p involving band 
2p23pter with a more distinctive phenotype comprising a prominent forehead, a 
depressed nasal bridge, posteriorly rotated ears, generalized hypotonia and a 
delayed fine and gross motor development 67. Some clinical manifestations of this 
Subject are similar to the Subject reported by Saffar et al., as indicated in Table 8. 
Based on the clinical features, this subject is likely to have true 2p duplication 
since his phenotype showed several similarities with the previously reported 
cases.  
Cytogenetic analysis confirmed this abnormality [This patient had 
karyotype of 46,XY,add (2)(p25)] . Therefore in the future FISH is needed to see 
the location of the duplication, Parental testing is needed to see whether the 
duplication is de novo or inherited. Then SNP array is warranted also to measure 
the exact size of duplication.  
 
 V.2.3. Subject 3 (Del 18 pter)  
Microscopically visible 18p deletions have been reported in numerous 
cases 11. Furthermore, familial microscopically visible 18p deletions have been 
reported as well 68,69. Nevertheless, none of these describe a sub-microscopic 
deletion of 18p11.3pter. Horsley et al. suggested that such small 18pter deletions 
are only associated with some degree of mental retardation. However, in addition 
to the mental retardation several distinctive dysmorphological features were noted 
in this Subject as indicated in Table 8 70. Some of these features are similar to the 
most consistent features caused by visible deletions of 18p, such as microcephaly, 
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hypertelorism and a low nasal bridge71. Based on the clinical features of this 
subject we presume she might have a large, microscopically visible deletion. 
However the cytogenetic analysis showed a normal karyotype (46,XX). Therefore 
further analyses (FISH and SNP array) are needed. 
 
V.2.4. Subject 4 (Dup 16qter)  
Maher et al reported three cases with 16q duplication. All these reported 
cases resulted from a parental translocation. Therefore it is difficult to compare 
the phenotype of pure 16qter duplication with the literature because some of the 
described features in these reported cases are caused by the coexistence of a 
partial autosomal monosomy 72. In summary, frequently noted features were 
mental retardation, growth retardation, a high forehead, a beaked nose, a long 
philtrum and a micropenis in males. In this Subject, only mental retardation and a 
high forehead were similar with the previous reported cases. In general, sub-
telomeric duplications only if they are small are more difficult to confirm than 
deletions and therefore this Subject needs to be confirmed with another analysis 
before the definite results are complete. Nevertheless, we assume this duplication 
will be confirmed because both the P070 and P036D probes identified the same 
duplication and the subject showed a few similar clinical features with previous 
reported cases, as noted in Table 8.  
 
V.2.5.Subject 5 (Del 10qter / dup 9pter)  
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 De Vries et al.reviewed 20 subject with a 10q26.1qter deletion and 
concluded that all subject have a consistent phenotype including mental disability 
11, growth retardation, microcephaly, a triangular face, hypertelorism, strabismus, 
a prominent nasal bridge, low set ears, micrognathia, a short neck, cryptorchidism, 
anal/urogenital, cardiac and renal anomalies. Overlapping features of this subject 
included: mental retardation, strabismus, low set ears, micrognathia and a short 
neck. In addition to the 10qter deletion 9pter duplication was identified with the 
P070 and P036D probe-sets. Therefore, this subject may also have some 
characteristics of a duplication of 9pter. Although several cases of duplication 9p 
were reported pure 9p terminal duplication are rare. Only three subject with a 
duplication of 9p22p24 have been previously reported 73. Clinical manifestations 
in those cases included MR, brachycephaly, wide-spaced eyes, apparently low set 
ears, down-turned corners of the mouth, and a mild hand anomaly. This subject 
had some similar clinical features such as MR, brachycephaly and low-set ears. 
Interestingly, this subject had a unilateral cleft lip also which has never been 
reported in both 10qter deletions and 9pter duplications. Based upon the MLPA 
results and the comparison to previous reported cases we suggest that the clinical 
features of this subject are caused by the 10qter deletion and the 9 pter 
duplication. Due to the presence both of deletion and duplication in this subject, 
unbalanced translocation is thought. Therefore cytogenetic result is needed to 
confirm microscopically visible unbalanced translocation (to see whether it is 
present or not). However in the cytogenetic analysis there was a normal karyotype 
(46,XX). We suggest that the translocation is very small, thus FISH and or array 
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is needed for further assessment. In addition, parental testing is needed to trace the 
balanced translocation in the parent.  
 
V.2.6. Subject 6 (Del 18pter / Dup 4pter)  
As discussed in Subject 3 an 18p deletion leads to a wide range of associated 
clinical features ranging from MR as the single manifestation to MR with severe 
dysmorphisms depending on the size of the deletion. Several phenotypic features 
in this subject, as indicated in Table 8, were similar to the most consistent 
microscopically visible 18p deletion features such as the microcephaly, the ptosis, 
the low nasal bridge, wide-spaced nipples, a clinodactily of the fifth fingers and 
strabismus71. In addition to the 18pter deletion, this subject has a 4pter duplication 
and therefore might also have characterictics of 4pter duplication. Takeno et al. 
reported a family with terminal 4pter duplication cases 74. Most consistent features 
were a severe or moderate mental retardation with behavior problems and a minor 
phenotypic alteration. Furthermore, Rodriguez et al. reported a case with a 4pter 
duplication without mental retardation and distinctive clinical features except with 
unusual reproductive history 75. In conclusion, both the clinical features of this 
subject and the MLPA results support the fact that her features are caused by a 
deletion of 18p. Unfortunately, in this Subject the cytogenetic analysis was not 
finished yet. Therefore the actual size of the deletion was not identified. It is 
difficult to conclude whether some of the features in this subject are caused by the 
duplication on chromosome 4pter since the clinical features of such duplication 
are only MR with behavior problems and minimal phenothypic characteristics.  
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Due to the presence both of deletion and duplication in this subject, unbalanced 
translocation is thought. Therefore cytogenetic result is needed to confirm 
microscopically visible unbalanced translocation (to see whether it is present or 
not). However in the cytogenetic analysis there was a normal karyotype (46,XX). 
We suggest that the translocation is very small, thus FISH and or array is needed 
for further assessment. In addition, parental testing is needed to trace the balanced 
translocation in the parent.  
 
V.2.7. Subject 7 (Dup 9pter)  
 Duplications of chromosome 9pter were discussed in Subject 5. However, 
in this subject it is only 9pter duplication without additional deletion like in 
Subject 5. Some phenotypic features of 9pter duplication, as reported by Franchi 
et al., were also noted in this subject (Table 8) 76. He had deep-set eyes, 
apparently low set ears and mild hand anomalies. Since some similarity with the 
previous reported case was noted in this subject and both of the STDs probes gave 
a similar result we presume that the clinical features in this subject are caused by 
terminal 9p duplication. Cytogenetic result was normal (46,XY). However, further 
confirmation (SNP Array) is necessary whereas duplications are more difficult to 
prove compared to the deletions. 
 
V.2.8.Subject 8 (Del XYqter)  
 No pure submicroscopic Xqter deletion has been reported 11. However 
Bates et al  reported microscopically visible Xqter deletion in female patient with 
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ovarian failure 76. This subject was noted to have distinctive clinical features as 
indicated in Table 8.  Due to a minimum amount of previously reported cases with 
Xqter subtelomeric deletion, it is difficult to compare with previously reported 
cases. Interpretation of this result is also difficult since the Xqter probe (P070 kit) 
is located in the Pseudo Autosomal Region (PAR 2 Region). This region consists 
of 800 Kb identical DNA sequences at the q telomeric ends of the X and Y 
chromosomes, called the pseudoautosomal region 2 (PAR2); another region of 
approximately 2500 Kb identical DNA sequences at the p telomeric ends of these 
chromosomes (PAR1).  
 Repetition of the analysis, using the P070 probe kit again, showed the 
same result. Since the deletion of this region does not explain the phenotype, we 
presume it might be due to a large Xq deletion or something in Y-chromosome. 
Furthermore, the cytogenetics result is normal (46,XY), therefore FISH and SNP-
array are needed. 
 
V.2.9.Subject 9 (del 4q / dup 10 q)  
There were 2 Subjects with the same aberration; however they have different 
clinical features (Table 8). Probe P036C was used initially in these samples was 
repeated two times and showed the same results. Reanalysis with P070 probe not 
confirmed the results. Possibly these results were caused by segmental 
duplications. Furthermore, this result indicated that the 10q probe in the P036C 
can detect different copy numbers. Due to different clinical features in those 
subject and the result of probe P036C was not confirmed by P070. 
 66
Polymorphisms were thought to explain this result because sequencing in these 
samples which is surrounding the probe 4q was undertaken also. However, no 
polymorphisms were found. Cytogenetics analysis was showed normal karyotype 
in both subjects (46,XY) 
 
V.2.10. Subject 10 (dup 21 pter/qter)  
 When the MLPA analysis with probe P070 identified a duplication of 21 p 
and 21q a trisomy 21 (Down Syndrome) was suspected. Further, cytogenetic 
analysis confirmed this result. There was a clinical suspicion before.   
 
V.2.11.Subject 11 (Dup 10pter)  
 In the initial analysis, using the probe P070, 10pter duplication was 
identified. However, reanalysis using the P036D probe did not confirm this 
duplication. The clinical features of this subject were compared to a similar 10pter 
duplication case in the ECARUCA database (case no 4224; www.ecaruca.net). 
However, except for the mental retardation, there were no overlapping clinical 
features. This patient had a normal karyotype (46,XY). The duplication could be 
due to a polymorphism although a very small duplication is still possible. 
Therefore, further analysis (SNP array) is warranted. 
 
V.2.12. Subject 12 (Dup 10qter)  
Duplications of chromosome 10q are recognized as a distinct syndrome. 
Numerous cases have been reported, and in most cases, the aberration is a 
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consequence of a familial balanced reciprocal translocation. Terminal duplications 
of 10q were considered to cause more severe features than proximal duplications 
(Han et al. 2004). In the initial analysis with the P070 probe 10qter duplication 
was identified. However, this result was not confirmed by reanalysis using the 
P036D probe. In this Subject mild characteristic features were noted in contrast to 
severe multiple congenital anomalies reported in 10qter duplication cases by Han 
et al 77. This patient had a normal karyotype (46,XY). The duplication in this 
Subject is might be due to a polymorphism although a very small duplication is 
still possible. The phenotype in this Subject did not similar with 10q duplication 
syndrome that has been described before. Therefore SNP array could help to 
know how big the deletion is 
 
V.2.14. Prevalence of STDs in the population 
It is difficult to calculate the actual prevalence of sub-telomeric 
chromosomal abnormalities in the Indonesian population before all identified 
cases are confirmed. However, the fact that several samples showed a sub-
telomeric abnormality confirmed that STDs are one of the causes of mental 
retardation in this population. If the prevalence is calculated based on the initial 
screening with probe P070 the prevalence of STDs in this population would be 8,5 
% (10/117). The prevalence would decrease to 5,1 % (6/117) if only the cases 
with a confirmed aberration, shown by both P070/P036D probe-sets including one 
case with consistent results after confirmed with P070 (sample with deletion in 
XYp), would be considered.  Koolen et al. proposed parental testing and a clinical 
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comparison with previously reported subjects with similar subtelomeric 
rearrangements, in order to exclude polymorphisms 12. In this study parental 
testing was not available yet but all cases were clinically compared to the 
available literature cases. Based on these findings, only subjects with overlapping 
clinical features compared to the reported cases should be counted. In that case, 
the prevalence would be 4,3% (5/117). The latter seems to be ‘a reasonable’ 
prevalence because it was calculated based upon both the confirmed MLPA 
results and the clinical features present in the subjects although microscopically 
visible translocations still cannot be excluded. Translocations are thought of since 
2 samples were detected which had both of a deletion and duplication. In addition, 
this prevalence is comparable to the prevalence of 5,4% found in the  Dutch 
population12. Similarly, Rooms et al. found 5,3% in the Belgian population 16. The 
prevalence of STDs in this research is almost consistent with those studies in 
Caucasian population.  
 
V.3. PWS/AS result 
Only subjects with clinical signs of PWS/AS were screened for these 
syndromes. However, none of them   showed a positive result. Jacobsen et al  
reported a high prevalence of AS among the mentally retarded 1,4% (4/285) in 
contrast to Vercesi et al who reported a very low prevalence of PWS / AS in their 
cohort (0/256) 78,79. However, the latter study calculated that there was no 
statistically significant difference between their prevalence number and 
Jacobsen’s. Several community based studies reported the prevalence of PWS is  
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1:25.000 and of AS is between 1:10.000 – 1:40.000 respectively79-84. Although 
PW/AS was not detected in our cohort, our result is overlapping with the result as 
studied by Vercesi et al. In addition, tested cohort in the Indonesian population is 
smaller than studied by Verseci and Jacobsen. For future research it has to be 
considered to use a larger cohort of samples to test for PWS/AS. 
 
V.4. Cytogenetics result 
Cytogenetics analysis in this study only showed one subject with trisomy 
21. Although the clinical examinations were performed very careful to exclude 
subject with suspicion of Down Syndrome, nevertheless we found one subject 
with trisomy 21 and two subject with different structural abnormalities. 
Two subjects were identified to have structural abnormality. One subject 
with duplication of 2p25 was confirmed by MLPA. One subject with deletion of  
4p was confirmed to have deletion 4p and duplication of 8p. Further analysis is 
needed to confirm MLPA result. 
Rauch et al. reported the highest prevalence of trisomy 21 (9,2%) among 
other chromosomal aberrations within the mentally retarded population85. 
However, the total prevalence of all microscopic visible chromosomal aberrations, 
including trisomy 13, trisomy 18 and other autosomal aberrations was reported to 
be 5,2 %. Down syndrome is excluded in this study, thus only small percentage of 
trisomy detected by our cytogenetics analysis.  
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The differences between the result and with another studies may result 
from difference of population studied (mild-moderate MR) compared to the 
reference (general MR population). 
 
V.5. Clinical examination protocol 
The standardized clinical examination protocol adapted from the RUNMC 
was very helpful to describe the dysmorphological features in the subjects and it 
offers a systematic approach to use in a clinical setting. However, it has to be 
taken into consideration that in some cases not all steps of the protocol could be 
completed. Good anamneses are difficult to carry out and often there is no 
complete medical record of the subjects. This might be caused by a lack of 
education and knowledge of the parents about the medical history and the motor 
milestones of their child. However, by using this standardized protocol the clinical 
examination of the subjects was more easily performed. 
 
V.6. Clinical Studies 
Dysmorphological assessments of MR subjects are helpful to establish 
genetic diagnosis. This study showed that one subject with a full expansion of the 
CGG repeat had major clinical sign of FXS i.e. mental retardation, shyness 
behavior, a long face, a pointed chin, long fingers and macroorchidism. In the 
clinical setting, these features could help the clinician to raise susceptibility of 
Fragile-X syndrome, if they found MR individuals with those clinical features. 
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 In order to discuss the clinical features among MR individuals with 
subtelomeric rearrangements, the discussion will be focused only in the MR 
individuals who had a positive subtelomeric rearrangement in both STD probe-
kits (5 subjects). Subjects with microscopically visible subtelomeric 
rearrangements were excluded (2 subjects).  
Microcephaly was found in 3 out of 5 subjects (60%). Eye abnormalities, 
including telecanthus, hypertelorism and ptosis were found in 5 out of 5 subjects 
(100%). Ears abnormalities including ears structure and position abnormality were 
found in 3 out of 5 subjects (60%). Nose abnormalities were found in 3 out of 5 
subjects (60%). Mouth area abnormalities were found in 5 out of 5 subjects 
(100%). Extremities abnormalities were found in 4 out of 5 subjects (80%) (See 
Table 1 in Appendix 8). Based on common features observed in subtelomeric 
rearrangements cases, the common clinical features in these subjects are 
microcephaly, ears, eyes, nose, mouth and extremities abnormalities. In clinical 
setting those clinical features should raise susceptibility of subtelomeric 
rearrangements if we found those features in individuals with MR. Furthermore, a 
study have been done by de Vries et al, 2001 suggested using their clinical check 
list to screen subtelomeric rearrangements in individuals with MR86. Thus, for the 
next study, de Vries checklist for subtelomeric screening may be considered.  
 
 
CHAPTER VI 
CONCLUSION AND FUTURE DIRECTIONS 
 
VI. 1. Conclusion 
The prevalence of FXS in this cohort was 1,65 % (2/121) in the whole 
population and 2,15 % (2/93) in the male population. Although not all STDs results 
could be finalized yet, “a reasonable” prevalence of STDs in the population was 
calculated to be 4,3% (5/117)  however, translocations are thought in 2 samples and 
therefore this still have to be confirmed in some cases by further analysis.  The 
prevalence of STDs also overlapped with a study in the Caucasian population 11,15. 
None of the selected cases in this cohort had PWS or AS and therefore it can 
be preliminarily concluded that the frequency of PW/AS is very low in this 
population. The low prevalence for PW/AS found in this cohort was similar with the 
previously reported prevalence in Caucasian population excluding Jacobsen’s study 
80-84. The prevalence of microscopic visible aberrations in this population is (3/ 122). 
The prevalence of FXS in the male population was similar than previously 
reported by Faradz et al. and the similar too (~ 2 — 3%) as reported in the Caucasian 
population 6,87-90 
 
1.  This research confirmed that the prevalence of STDs is higher than 
Fragile-X and become major genetic abnormalities causing mental 
retardation in this population, excluding Down Syndrome and other 
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microscopic visible cytogenetic abnormalities. The results presented in 
this report represent the major genetic causes of MR in Indonesia, 
excluding Down Syndrome. This is the first screening study for STDs 
and PW/AS in the Indonesian population. Despite some of STDs 
results still need to be confirmed with further analyses we proved that 
STDs are a major cause of MR in the Indonesian population.  
2.  There was an association between genotype and phenotype of the 
affected individuals and each association were discussed in discussion 
section. 
 
VI.2. Future Directions 
In next studies in the same field, a good planning and scheduling, particularly 
in time and financial support, has to be considered. Also, the right orders of 
laboratory assessments, as written in the protocols, have to be followed correctly. The 
results of this research project should raise the level of awareness concerning the 
existence of important genetic causes of MR in the Indonesian community. 
Furthermore the results of this research can be used as a basis for genetic counseling 
in the Indonesian population.  
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SUMMARY 
 
Mental retardation (MR) is still a major health problem in all countries 
including the developed countries. Some etiologies of MR are known, like 
biochemical causes, chromosomal abnormalities, mutations of single gene 
(Mendelian disorders/mitochondrial disorders), multi-factorial disorders or because of 
environmental factors such as toxins, infections, and trauma. However, genetic 
factors have a crucial role since approximately half of MR cases have a familial 
history 
The knowledge of genetic factors of mental retardation by cytogenetics, 
molecular and clinical assessment is an advantage in giving early diagnosis and 
prevention through genetic counseling to subject’s family. These serve as diagnostics 
tool in determining genetic factor that may play role as etiological cause of MR. 
Nowadays, the above mentioned assessments could well be done in Indonesia. But 
due to lack of facilities in Indonesia, further molecular assessments have to be carried 
out in other centre abroad.  
 Up till now there are only few studies on MR in Indonesian population carried 
out by Indonesian researchers or in collaboration with researchers abroad. No MR 
protocol has been applied for diagnosis of MR in Indonesia, thus this study aims to 
establish MR protocol for diagnosis in Indonesia. More over genetic assessments as 
an etiological diagnostic tool for MR have not yet been recognized as a routine 
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diagnostic tool in Indonesia. The procedures for genetics assessment will be the main 
focus of this research in order to apply this MR protocol for diagnosis in Indonesia. 
The main research question is what the percentage of genetic factors playing a 
role in the etiology of mental retardation in Indonesian Population. The advantages 
comes out from this research will be encouraging public awareness of genetic 
diseases. Furthermore, the advantage of this research will be laying down a basis for 
genetic counseling. Genetic counseling is not that common in Indonesia, though with 
increasing public awareness in genetic diseases there will be an increasing demand 
for genetic counseling.  
Mental retardation (MR) refers to substantial limitations in present 
functioning. It is characterized by significant subaverage intellectual functioning i.e 
IQ < 70, existing concurrently with related limitations in two or more of the 
following applicable adaptive skill areas: communication, self-care, home living, 
social skills, community use, self-direction, health and safety, functional academics, 
leisure and work. The  age of onset should be before age 18.  
Many environmental and genetic factors can cause MR like biochemical 
causes, chromosomal abnormalities, mutations of single gene (Mendelian 
disorders/mitochondrial disorders), multi-factorial disorders or because of 
environmental factors such as toxins, infections, and trauma. Nevertheless, genetic 
factors have a crucial role since approximately half of MR cases have a familial 
history. 
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Several genetic causes of MR are known, most common are the large 
microscopic numerical and structural cytogenetic abnormalities (> 4 MB), such as 
trisomy 21 (Down syndrome), large deletions and duplications and unbalanced 
reciprocal and Robertsonian translocations. Down syndrome is the best known 
chromosomal abnormality as cause of MR with the highest prevalence. This 
abnormality occurs due to meiotic non-disjunction, mostly maternal with a result an 
extra 21 chromosome in the child. With routine chromosomal analysis, trisomies like 
trisomy 21 can be easily detected. 
Individuals with MR, dysmorphic features with or without positive family 
history (usually without positive family history) and without microscopic 
chromosomal abnormalities can be due to cryptic chromosomal rearrangements like 
sub-microscopic sub-telomeric deletions or duplications. This has been identified as 
another common cause of MR. 
X-Linked Mental Retardation (XLMR) can be generally classified into two 
categories; syndromic XLMR (S-XLMR) that are associated with a specific or 
characteristic phenotype and non-syndromic XLMR (NS-XLMR) that do not present 
with consistent clinical features. Non-syndromic XLMR was thought to be more 
frequent than the syndromic XLMR conditions. Nevertheless, due to the development 
of molecular techniques which is used to classify family and better detailed 
examination in the patient, the proportion of S-XLMR will be increase 
simultaneously with the decrease of NS-XLMR. 
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Fragile-X syndrome is one of the XLMR and become the most common 
inherited abnormality causing MR. This syndrome is commonly seen in males. 
However, females can also be affected. Approximately 50-60% of female full 
mutation carriers will have borderline to mild mental retardation. The Fragile X 
syndrome is due to a mutation in a gene on the X chromosome leading to hyper-
expansion of a trinucleotide (CGG) repeat sequence. There is a repetitive CGG 
sequence on the 5’ÚTR of the FMR1 gene and normal individuals have 
approximately 5 to 44 CGG repeats. There is a gray zone of 45 to 54 repeats that can 
be associated with minor instability from generation to generation. The premutation is 
defined as 55 to 200 repeats and the full mutation of the FMR1 gene involves an 
expansion of >200 CGG repeats and is clinically associated with features of Fragile-
X syndrome.  
Prader-Willi and Angelman syndrome are genetic disorders that show 
different levels of mental retardation. Prader-Willi syndrome (PWS) features mild to 
moderate mental retardation and Angelman syndrome (AS) severe mental retardation. 
These syndromes can occur due to absence of the paternally or maternally derived 
chromosome 15q11-13 region by several genetic mechanisms. When there is absence 
of paternal chromosome 15q11-13 region it will manifest as Prader-Willi Syndrome, 
while absence of the maternal chromosome 15q11-13 region will manifest as 
Angelman syndrome.  
Approximately 70% individuals with PWS and AS have a deletion of one 
chromosome 15 involving bands 15q11-q13. Whereas in PWS uniparental maternal 
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disomy occurs in about 25% of cases, in AS  uniparental paternal disomy occurs in 
only 1% of cases. Both syndromes and in particular AS can also be caused by 
mutations in imprinted genes with potentially high recurrence risks. 
II.1.3 Genetic diagnosis 
Genetics diagnosis for MR individual is based on dysmorpologycal and 
laboratory assesement. Most known genetics syndrome in MR is associated with 
specific features10. Laboratory assessment is considered as the tool to confirm the 
genetics diagnosis based on clinical examination. Nevertheless, some genetics 
etiology could not be diagnosed with dysmorphologycal assessment. Thus, laboratory 
assesement is needed. However, dysmorphologycal assessment is the most important 
thing to do before laboratory and other assessment.   
Chromosomal analysis is the most valuable analysis to reveal genetics cause 
of MR. With routine chromosomal analysis, numerical abnormalities such as trisomy 
13,18, and 21 or monosomy such as monosomy X (45,X/Turner syndrome) can be 
easily detected. Furthermore chromosomal analisys can reveal some structural 
chromosome abnormality such as deletion / duplication (> 4 Mb), insertion, 
derivation, and translocation.  That is why chromosome analysis should be done as 
the first laboratory assessment for the patient.  
Since Fragile-X syndrome is considered as the most common inherited 
abnormality causing MR. Laboratory analysis for the Fragile-X syndrome is the most 
significant assessment after chromosome analysis. Although fragile site in the 
Fragile-X syndrome is detected in chromosomal analysis, nevertheless subject with 
 79
permutation or mosaic permutation – full mutation of Fragile-X syndrome might not 
detected by routine chromosome analysis. That is why confirmation analysis shold be 
done with molecular assessment. 
Subtelomeric deletions and duplications (< 4Mb) are not visible by 
microscope. Thus molecular analysis of this abnormality is required. Based on the 
high incidence of this abnormality in MR individual, molecular screening of this 
abnormality is very important if the chromosome analysis and Fragile-X analisys are 
fail to detect the genetic cause of MR. 
PW/AS analysis could be performed to the MR individual with suspicion of 
this abnormality. Since there are some genetics diseases have similar features with 
PW/AS syndrome, this analysis is valuable to verify genetic diagnosis of MR 
especially to the MR individuals with suspicion of this syndrome. 
This study is an observational survey. Pupils have been examined from 
several special schools for the mentally retarded in Semarang namely SLB Negeri, 
SLB Pelita Ilmu, and SLB Hj. Soemijati. Pupils with a known exogenic cause, such 
as pre-, ante- and postnatal traumas, or a history of asphyxia, non cooperative pupils 
and children of parents who declined to sign the informed consent form, were 
excluded from research participation. Also subjects with a clinical suspicion of Down 
Syndrome. 
Routine chromosome analysis was performed in Molecular and Cytogenetic 
laboratory of Center for Biomedical Research, Faculty of Medicine Diponegoro 
University Semarang. DNA analysis of the Fragile-X syndrome, Prader-
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Willi/Angelman syndrome and sub-telomeric deletions and deletions (STDs 
Analysis) with MLPA (Multiplex Ligation Probe Amplification were performed in 
the Radboud University Nijmegen (Laboratory for DNA diagnostics, RUNMC). 
Samples were taken from 122 mentally retarded pupils with an average age 
between 6 and 25 years. The parents were also involved in order to obtain the family 
history. Furthermore, samples of parents, of pupils with a proven genetic 
abnormality, were taken in order to determine de novo or inherited occurrence. Not 
all parents were available for sampling. 
 After a clinical examination 5 mL heparinized blood (for chromosome 
analysis) and 5-10 mL EDTA blood (for DNA analysis) were drawn from each 
individual. Chromosome preparation, chromosome analysis and DNA Isolation were 
performed following the standard operating procedure of Center for Biomedical 
Research (CEBIOR) Semarang.  
CGG repeats in FMR-1 were amplified with PCR technique. Southern blot 
was used to confirm the CGG  results.  MLPA is a new method for relative 
quantification of about 40 different DNA sequences in an easy to perform reaction. 
This technique has been developed and first described by MRC-Holland. To detect 
STDs in samples, P070 probe-kit and P036D was used using MLPA analysis. MLPA 
is a new method for relative quantification of about 40 different DNA sequences in an 
easy to perform reaction. This technique has been developed and first described by 
MRC-Holland. To detect PW/AS in the samples P028 methylathion specific probe-kit 
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was used. All procedures mentioned above were performed following a standard 
operational protocol from the Department of DNA Diagnostics of the RUNMC.  
From 186 pupils selected in three special schools, only 122 pupils can be included in 
further analysis based on the inclusion and exclusion criteria.   
A total of 122 subjects with developmental disability from three special 
schools in Semarang were analyzed for trinucleotides repeats expansion (PCR 
Analysis on agarose and genescan). To determine exact number of CGG repeats, PCR 
products were analyzed by Fragment Length Analysis (genescan). Southern Blotting 
was used when the PCR / Fragment Length Analysis were not clear; there was no 
PCR product in agarose gel (1 sample), or when the CGG repeats were too high (1 
sample) and when single allele (can be homozygous samples or normal and expanded 
allele) found in woman samples (9 Samples). Southern Blot analysis was performed 
in those samples which identified one subject with a full CGG expansion, one subject 
with a mosaic pattern (premutation and full mutation) and none of the females were 
found to have a CGG expansion. The CGG repeat from those samples then 
redistributed.  The most frequent CGG repeat in this population was 29 CGG repeat, 
then followed by 28,30,35 & 36 respectively. 
To identify sub-telomeric deletions and duplications (STDs) analysis by 
MLPA was carried out. One male was excluded for STDs analysis because of a 
positive FMR-1 result. However one sample cannot be analyzed using MLPA 
analysis due to bad DNA. Therefore 120 samples were tested with MLPA analysis. 
The initial screening with the P070 kit (MRCH) which contains probes in all 
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telomeric regions of the different chromosomes showed 13 samples with 
subtelomeric rearrangements. Re-analysis using another probe-set (P036D) by DNA 
Diagnostic RUNMC confirmed that 8 out of 13 indeed had a sub-telomeric 
rearrangement. One sample was excluded from further analysis after the result of 
MLPA was confirmed with cytogenetics showing trisomy 21 (Down syndrome). 
Three samples that did not showed same aberration by confirmation with P036D 
probe were considered most likely because of polymorphism but it still could be 
something (very small deletion / duplication). 
The family of the proband with a full CGG expansion was visited and blood 
samples were taken from all family members in order to detect carriers and possibly 
affected individuals. Several carrier females were identified in the family; the mother 
had a normal allele and an elevated band size in PCR amplification which was 
confirmed by Fragment Length Analysis and Southern Blot. The first daughter had 1 
normal allele and 1 allele in the premutation range. Two brothers of the proband had 
a mosaic premutation allele which was assessed by PCR and fragment length analysis 
and confirmed by Southern Blot. The second daughter had normal alleles. The 
youngest daughter showed 1 normal allele and 1 fully expanded allele which was 
assessed by Southern Blot. Except for the affected proband all sibs and the carrier 
mother apparently had a normal intelligence. However, one male had learning 
difficulties. 
Cytogenetic preparations were carried out in all samples; One sample with 
trisomy 21 was detected, two with structural abnormalities [46,XY,del(4)(p16) and 
 83
46,XY,add (2)(p25)] and the others showed normal karyotype. Only subjects with 
clinical signs of PWS/AS were screened for these syndromes. However, none of them 
showed a positive result. 
The standardized clinical examination protocol adapted from the RUNMC 
was very helpful to describe the dysmorphological features in the subjects and it 
offers a systematic approach to use in a clinical setting. By using this standardized 
protocol the clinical examination of the subjects was more easily performed. 
 In the MR individuals who had a positive subtelomeric rearrangement in both 
STD probe-kits (5 subjects), microcephaly was found in 3 out of 5 subjects (60%). 
Eye abnormalities, including telecanthus, hypertelorism and ptosis were found in 5 
out of 5 subjects (100%). Ears abnormalities including ears structure and position 
abnormality were found in 3 out of 5 subjects (60%). Nose abnormalities were found 
in 3 out of 5 subjects (60%). Mouth area abnormalities were found in 5 out of 5 
subjects (100%). Extremities abnormalities were found in 4 out of 5 subjects (80%).  
The prevalence of Fragile-X Syndrome (FXS) in this cohort was 1,65 % 
(2/121) in the whole population and 2,15 % (2/93) in the male population. Although 
not all STDs results could be finalized yet, “a reasonable” prevalence of STDs in the 
population was calculated to be 4,3% (5/117).  The prevalence of STDs also 
overlapped with a study in the Caucasian population. 
None of the selected cases in this cohort had PWS or AS and therefore it can 
be preliminarily concluded that the frequency of PW/AS is very low in this 
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population. The low prevalence for PW/AS found in this cohort was similar with the 
previously reported prevalence in Caucasian population excluding Jacobsen’s study.  
The prevalence of FXS in the male population was similar than previously 
reported by Faradz et al. and being similar too as reported in the Caucasian 
population  
This is the first screening study for STDs and PW/AS in the Indonesian 
population. Despite some of STDs results still need to be confirmed with further 
analyses we proved that STDs are a major cause of MR in the Indonesian population.  
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Appendix 1. Figure of FMR-1 Amplification result on agarose and genescan 
from patients SM-30C and SM-34C 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1A. Agarose gel of FMR-1 amplification from SM-30C and SM-34C 
Lane 1 (SM-30 C) no PCR product was detected 
Lane 3 (SM-34 C) showing high CGG repeats / premutation allele (~500 bp) 
Lane 2,4,5, are male normal subjects 
Lane 6 is premutation female control 
Lane 7 is normal female control 
Lane 8 is marker 
 
 
1 2 3 4 5 6 7 8 
300 bp 
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Figure 1.B. Genescan result from SM-30 C 
There was no peak detected by Fragment Length Analysis in this subject. The 
peak on the 230 CGG repeats and 305 repeats are artifact. This confirms that there 
is no PCR product. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.C. Genescan result from SM-34 C 
Peaks were detected on ~468 CGG repeats and 698 CGG repeats. This analysis 
confirmed that there were mosaic permutation alleles in this subject. 
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Appendix 2. Figure of Southern Blot analysis result of SM-30C, SM-34C and 
some homozygous females 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Southern Blot analysis result of SM-30C, SM-34C and some 
homozygous females (correspond to table 6). 
 
Lane 1 (SM-30 C) Full mutation;Showing expanded allele 
Lane 2 (patient not in this population) Full mutation;Showing expanded allele 
Lane 3 (SM-34C) Mosaic premutation to full mutation; Showing expanded allele 
(>5,2Kb) and slight smear above the unmethylated allele (2,8 Kb). 
Lane 4-9; (4; N-52), (5; N-54), (6; N-52), (7; PI-19), (8; PI-21), (9; SM-20): 
Showing two normal female alleles 
 
Work with a methylation sensitive enzyme allows us to distinguish between 
methylated and unmethylated FMR1 alleles. Normal female samples (Lane 4-9) 
showed clear band of 2,8 kb and 5,2 kb correspond to unmethylated normal allele 
and methylated normal allele due to X-inactivation process respectively. Full 
mutation samples showed an expanded smear correspond to high CGG repeats. 
Lane 3 showed expanded allele and slight smear above the unmethylated allele 
means that there was a mosaic pattern of permutation to full mutation. 
 
  1      2    3     4      5      6     7     8     9   
2,8 Kb
5.2 Kb
Normal 
Premutation 
Full mutation 
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Appendix 3. Figure of Southern Blot analysis on family members from SM-
30C 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Southern Blot analysis of family members from SM-30C 
(correspond to Table.9) 
 
Lane 1; Father; Normal allele 
Lane 2; Mother; showing normal allele and premutation allele 
Lane 3; Sister; showing normal allele and premutation allele  
Lane 4; Brother; showing premutation allele 
Lane 5; Brother; showing mosaic premutation allele  
Lane 6; Sister; showing two normal alleles 
Lane 7; Sister; One normal allele and one full mutation allele 
 
Normal male sample (Lane 1) showed clear band of 2,8 kb correspond to 
unmethylated normal allele. Normal female sample (Lane 6) showed clear band of 
2,8 kb and 5,2 kb correspond to unmethylated normal allele and methylated 
normal allele due to X-inactivation process respectively. Lane 7 showed a clear 
band of 2,8 kb correspond to unmethylated normal allele and expanded allele 
correspond to full mutation allele. Premutation females sample (Lane 2 & 3) 
showed a clear band of 5,2 kb correspond to unmethylated normal allele and 
higher band above 2,8 kb in premutation range. Premutation male samples (Lane 
4&5) showed a higher band / smear above 2,8 kb in permutation range. Since the 
permutation allele is unstable, permutation allele sometimes was identified as two 
bands above 2,8 kb or smear as showed in lane 2,3 & 4.  
2,8 Kb
5.2 Kb
   1      2      3      4      5      6        7     
Normal 
Premutation 
Full mutation 
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Appendix 4. Karyotype of subjects with chromosome abberation 
 
 
Figure 4A. Karyotype of subject N-10  
 
 
 
Figure 4B. Karyotype of subject PI-14   
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Figure 4C. Karyotype of subject N-34 
 
Chromosome analisys with G-Banding technique showed 46,XY,del(4)(p16.3) 
[fig 4A], 46,XY,add(2)(p25.3) [fig 4B] and 47XY,+21 [fig 4c]. 
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Appendix 5. Ethical Clearance 
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Appendix 6. Informed Consent 
 
INFORMED CONSENT 
 
 
Yang bertanda tangan dibawah ini: 
 
 
 Nama  : 
 Orang tua dari : 
 Alamat  : 
 
 
Menyatakan kesediaan dilakukan pengambilan darah, pengambilan foto dan pemeriksaan 
fisik terhadap anak saya tersebut diatas untuk diteliti kemungkinan penyebab factor 
genetic yang menyebabkan retardasi mental/ autis tanpa dipungut biaya.  
Apabila ternyata terdapat kelainan pada anak saya, saya tidak berkeberatan bila hasil-hasil 
tersebut (pengambilan foto, pemeriksaan fisik dan hasil laboratorium) akan digunakan 
sebagai laporan pada jurnal ilmiah terkait 
 
Demikian pernyataan ini saya tanda tangani dengan kesadaran penuh dan tanpa paksaan 
dari pihak manapun. 
 
 
 
Semarang,       
 
 
 
 
 
(    ) 
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Appendix 7. Physical Examination Form 
Dr:    DATE:   LOCATION :  
 
 
Family/proband 
Gene Mutation DNA/fam.nr. Laboratory 
    
 
 
Clinical photographs 
yes/no 
Archived where Consent patiënt/parents for use in 
teaching and/or scientific 
publications/meetings 
 
Clinical genetic conclusion  
 
Diagnosis Recurrence risk Remarks  
1 
 
  
2 
 
  
3 
 
  
 
 
Relevant patiënt organisation:   
 
 
 
Literature given to patiënt/parents: 
 
 
 
NAME AND  ADDRESS OF REFERRING/TREATING DOCTORS 
 
 Name Specialism  Address 
 
 
1. 
 
2. 
 
3. 
 
Date Name supervisor Signature of supervisor 
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PEDIGREE 
 
Consanguinity yes/no 
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HISTORY 
 
 
Conception  
 
Exposition by profession/recreational? 
 
Profession of man/father:  Profession of woman/mother: 
 
Pregnancy: 
                                       
fluxus   diabetes mellitus   
fever   medicines 
skin problems  smoking 
infections  alcohol 
trauma   X-ray/radiation 
toxicosis   other intoxications 
 
 
Prenatal care from ………weeks GA by: 
Prenatal diagnosis (indication and results): 
Ultrasound examination (indication and results): 
 
 
Delivery: by whom where 
gestational age spontaneous 
induction  artificial labour 
position  duration   Apgar score 
amniotic fluid umbilical cord  placenta 
W              (P:         ) L:               (P:         )   OFC:               
(P:          ) 
asphyxia  icterus    
artificial ventilation: how long in hospital: 
 
Neonatal period: 
feeding problems 
hypotonia 
 
 
Psychomotor development:    regression yes/no 
laughing                  grasping    rolling over  
making noises   sitting with help  sitting without help 
standing  walking   speech 
social contact   school     
behaviour 
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Past ilnesses/admissions/operations 
 
 
 
 
 
Paramedical treatment (physiotherapy, speech therapy etc.) 
 
 
 
 
Prescribed medicines 
 
 
 
 
 
SPECIFIC HISTORY  
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EXAMINATION  Date:   Age at examination: 
 
General aspects 
 
Bodily habitus:     Developmental level 
      motor : 
      cognitive: 
  
 
 
 
 
     
Stature in proportion: yes/no 
 
 
Measurements        P/SD                P/SD 
weight  
 
length/height 
 
OFC 
 
spanwidth 
 
US/LS 
 
Sitting height 
 
 
ICD 
 
OCD 
 
IPD 
 
Palp. fissures  
               
Corneadiameter  
                
 
fontanel 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
OD 
OS 
 
 
 
 
 
  Ear length 
           
 
Nipple distance 
 
 
Chest 
circumference 
 
 
Penile length 
 
 
Testis volume  
              
 
Foot length  
            
 
Hand length  
            
 
Palml ength  
            
 
finger III length  
                   
AD 
AS 
 
 
 
 
 
 
 
 
 
 
 
ri 
le 
 
ri 
le 
 
ri 
le 
 
ri 
le 
 
ri 
le 
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HEAD 
 
General:   form            micro/retrognathia  
 
   forehead    mimics   
 
   mid face       
 
Eyes  :  position      form 
 
   hypo/hypertelorism   tele/epicanthus 
   blepharophimosis ri/le   ptosis ri/le 
   microphthalmos ri/le   iris coloboma   
 
   cornea    eye lids 
 
   eye colour    eye movements 
 
Ears  : position    fistula 
 
   form    appendages 
 
Nose  : form    philtrum 
 
   choanae    
 
Mouth  : size    palate (uvula) 
 
   lips    teeth 
 
   tongue    gingiva 
 
Neck : : webbing    hairline 
 
   fistula    movements 
 
 
 
 
TRUNK 
 
Thorax  : form    heart 
 
   mammae    lungs 
 
   nipples 
 
    
Abdomen : liver    spleen   
 
   kidneys    hernia 
     
   diastasis mm. recti   abdominal wall      
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Back  : kyphosis/lordosis/scoliosis   spina bifida 
 
   sacrale dimple    anus 
 
Genitalia  : puberty stages (Tanner) A M  P G 
 
   testis 
 
LIMBS 
 
Arms  : proportions    upper arm 
 
   muscle tone    under arm 
 
   hands: syn/poly/clino/camptodactyly  
   
     palm creases 
 
 
Legs  : proportions    upper leg 
 
   spiertonus    lower leg 
 
   feet: syn/poly/clino/camptodactyly 
      
     pes cavus/planus 
 
Hypermobility score: thumb to under arm 5th finger > 90o   
 elbows > 10o 
 
   knees > 10o  hands to floor 
 
   
   Total ....../9 
Contractures? 
 
SKIN  
 Hair (incl.eyebrows, eyelashes)    sweating 
 
 elasticity       nails 
  
 pigment changes     others 
 
 bullae/ichthyosis/hyperkeratosis 
 
 vascular abnormalities 
 
 
NERVOUS SYSTEM 
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Summary 
 
 
 
 
 
 
 
 
 
Preliminary conclusion and differential diagnosis 
 
 
 
 
 
 
 
 
 
 
Additionnal investigations/management 
 
 
 
 
 
 
 
Results of additionnal investigations (with dates!) 
 
biochemistry/clinical chemistry 
 
 
cytogenetics 
 
 
DNA 
 
 
imaging 
 
 
IQ 
 
consultands 
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Appendix 8. Clinical features summary on subjects with positive result of 
subtelomeric rearrangement in both STD probe-kits (5 Subjects). 
 
 
Clinical Features Total Percentage 
Level of mental retardation   
     Mild 3 60% 
     Moderate 2 40% 
Height 2 40% 
    Short stature 2 40% 
OFC 3 60% 
     Microcephaly 3 60% 
Behaviour problems *) 1 20% 
     Autistic 1 20% 
     Aggressive 1 20% 
Other features   
    Cranial/Face  *) 2 40% 
        Brachycephaly 1 20% 
        High Forehead 1 20% 
        Retrognathia 1 20% 
    Ears *) 3 60% 
        Low-Set 1 20% 
        Prominent 2 40% 
        Posteriorly rotated 2 40% 
       Prominent anti-helix 1 20% 
    Ocular region *) 5 100% 
        Ptosis 2 40% 
        Telecanthus 3 60% 
        Strabismus 2 40% 
        Downslanting palpebral 
fissure 1 20% 
        Deep-set eyes 1 20% 
        Hypertelorism 1 20% 
    Nose *) 3 60% 
        Flat nose 1 20% 
        Broad Nasal bridge 1 20% 
        Deviated columnella 1 20% 
        Depresed nasal bridge 1 20% 
        Broad base 1 20% 
    Mouth area *) 5 100% 
       Short philtrum 3 60% 
       Teeth overbite 1 20% 
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       High arched palate 1 20% 
Clinical Features Total Percentage 
       Cleft lip 1 20% 
       Downturned of mouth 1 20% 
    Thorax *) 2 40% 
       Pectus Excavatum 1 20% 
       Wide-spaced nipples 1 20% 
    Extremities *) 4 80% 
      Tapering fingers 1 20% 
      Clinodactily 5th finger 1 20% 
      Sandal gaps 1 20% 
      Cubitus valgus 1 20% 
      Short 5th finger 1 20% 
      Single palmar crease 1 20% 
    Other features *) 1 20% 
       Delayed speech 1 20% 
       Poor coordination 1 20% 
 
*) One subject may have one or more abnormalities in this region 
 
 
 
 
